Physiology of acetic acid bacteria and their role in vinegar and fermented beverages by Lynch, Kieran M. et al.
UCC Library and UCC researchers have made this item openly available.
Please let us know how this has helped you. Thanks!
Title Physiology of acetic acid bacteria and their role in vinegar and
fermented beverages
Author(s) Lynch, Kieran M.; Zannini, Emanuele; Wilkinson, Stuart; Daenen, Luk;
Arendt, Elke K.
Publication date 2019-04-02
Original citation Lynch, K. M., Zannini, E., Wilkinson, S., Daenen, L. and Arendt, E. K.
(2019) 'Physiology of acetic acid bacteria and their role in vinegar and
fermented beverages', Comprehensive Reviews in Food Science and
Food Safety. doi: 10.1111/1541-4337.12440
Type of publication Article (peer-reviewed)
Link to publisher's
version
https://onlinelibrary.wiley.com/doi/abs/10.1111/1541-4337.12440
http://dx.doi.org/10.1111/1541-4337.12440
Access to the full text of the published version may require a
subscription.
Rights © 2019, Institute of Food Technologists. Published by John Wiley &
Sons Inc. This is the peer reviewed version of the following article:
Lynch, K. M., et al (2019) 'Physiology of acetic acid bacteria and
their role in vinegar and fermented beverages', Comprehensive
Reviews in Food Science and Food Safety. doi: 10.1111/1541-
4337.12440, which has been published in final form at
https://doi.org/10.1111/1541-4337.12440. This article may be used
for non-commercial purposes in accordance with Wiley Terms and
Conditions for Use of Self-Archived Versions.
Embargo information Access to this article is restricted until 12 months after publication by
request of the publisher.
Embargo lift date 2020-04-02
Item downloaded
from
http://hdl.handle.net/10468/7852
Downloaded on 2020-06-06T01:49:14Z
1 
 
Physiology of Acetic Acid Bacteria and Their Role in Vinegar and 1 
Fermented Beverages 2 
 3 
Kieran M. Lynch1, Emanuele Zannini1, Stuart Wilkinson2, Luk Daenen2, and Elke K. 4 
Arendt1,3* 5 
1School of Food and Nutritional Sciences, University College Cork, Cork, Ireland 6 
 2Global Innovation & Technology Centre, Anheuser-Busch InBev nv/sa, Brouwerijplein 1, 3000 7 
Leuven, Belgium 8 
3APC Microbiome Ireland, University College Cork, Cork, Ireland 9 
 10 
 11 
 12 
* Corresponding author: 13 
Mailing address: School of Food and Nutritional Sciences, University College Cork, Cork, 14 
Ireland. 15 
Tel +353 21 490 2064; Fax +353 21 427 0213 16 
E-mail address: e.arendt@ucc.ie 17 
 18 
 19 
 20 
 21 
Short title: Microbiology of Acetic acid bacteria 22 
 23 
 24 
Keywords: Acetic acid bacteria, oxidative fermentation, exopolysaccharides, vinegar, 25 
Vitamin C. 26 
 27 
 28 
2 
 
ABSTRACT 29 
Acetic acid bacteria (AAB) have, for centuries, been important microorganisms in the 30 
production of fermented foods and beverages such as vinegar, kombucha, (water) kefir and 31 
lambic beer. Their unique form of metabolism, known as “oxidative” fermentation, mediates 32 
the transformation of a variety of substrates into products which are of importance in the food 33 
and beverage industry and beyond; the most well-known of which is the oxidation of ethanol 34 
into acetic acid. Here, a comprehensive review of the physiology of acetic acid bacteria is 35 
presented, with particular emphasis on their importance in the production of vinegar and 36 
fermented beverages. In addition, particular reference is addressed towards Gluconobacter 37 
oxydans due to its biotechnological applications, such as its role in Vitamin C production. The 38 
production of vinegar and fermented beverages in which AAB play an important role is 39 
discussed, followed by an examination of the literature relating to the health benefits associated 40 
with consumption of these products. Acetic acid bacteria hold great promise for future 41 
exploitation, both due to increased consumer demand for traditional fermented beverages such 42 
as kombucha, and for the development of new types of products. Further studies on the health 43 
benefits related to the consumption of these fermented products and guidelines on assessing 44 
the safety of AAB for use as microbial food cultures (starter cultures) are, however, necessary 45 
in order to take full advantage of this important group of microorganisms.  46 
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Introduction 47 
Acetic acid bacteria (AAB), first described as “vinegar bacteria” by Louis Pasteur over 150 48 
years ago, are an important and diverse group of bacteria involved in the production of 49 
fermented foods and beverages, especially known for their production of acetic acid (ethanoic 50 
acid) in the making of vinegar (Hutkins, 2006; Pasteur, 1864). Acetic acid bacteria are 51 
characterized by their ability to oxidize carbohydrates, alcohols and sugar alcohols (polyhydric 52 
alcohols or polyols) into their corresponding organic acids, aldehydes or ketones, in a process 53 
termed “oxidative fermentation”, from which they gain energy (Taban & Saichana, 2017). This 54 
unique property also has applications in the production of industrially-relevant compounds and 55 
has primarily been exploited in the synthesis of ascorbic acid (Vitamin C) and miglitol (an 56 
antidiabetic drug used in the treatment of type II diabetes mellitus) (Shinjoh & Toyama, 2016; 57 
Taban & Saichana, 2017). Some genera of AAB are notable for their production of a variety 58 
of exopolysaccharides (EPS), the most valuable of which are bacterial cellulose (BC) and 59 
acetan. BC offers several advantages over plant-derived cellulose, particularly because it is free 60 
of hemicellulose and lignin associated with cellulose (Dağbağlı & Göksungur, 2017). Acetic 61 
acid bacteria are associated with, and have been isolated from, carbohydrate-rich and acidic 62 
environments such as fruits and flowers, and are involved in the production of a variety of 63 
fermented foods and beverages including vinegar, kombucha, lambic beers, kefir and nata de 64 
coco (Table 1). They also play an important role in the cocoa fermentation process (Pothakos 65 
et al., 2016). Unsurprisingly, AAB have also been associated with the spoilage of foods and 66 
alcoholic beverages such as beer, wine, cider and fruit juices (Taban & Saichana, 2017). The 67 
purpose of this review is to provide an overview of the physiology and biochemistry of AAB 68 
and to provide an understanding of how the unique capabilities of these microorganisms are 69 
important in the production of vinegar and other fermented beverages. Other technologically-70 
relevant aspects, such as EPS biosynthesis and their role in the bioconversion of products useful 71 
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in the food, chemical and pharmaceutical industries, such as ascorbic acid, are also considered. 72 
While recent reviews from others such as Ho et al. (2017) and De Roos & De Vuyst (2018a) 73 
have addressed specific topics, the aim here was to provide a broad and comprehensive review 74 
on the physiology and application of AAB (De Roos & De Vuyst, 2018a; Ho, Lazim, Fazry, 75 
Zaki, & Lim, 2017).  76 
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Characteristics of the AAB and their identification 77 
Acetic acid bacteria are Gram-negative or Gram-variable, obligate aerobes, and are classified 78 
in the family Acetobacteraceae. They are non-spore forming, ellipsoidal to rod-shaped cells 79 
that can occur singly, in pairs or in short chains (Malimas et al., 2017). The members of the 80 
Acetobacteraceae family are separated into two groups, the acetous and the acidophilic groups, 81 
of which AAB are included in the former (Komagata, Iino, & Yamada, 2014). Eighteen genera 82 
are currently reported in the acetous group; the most important in terms of fermented foods are 83 
Acetobacter, Gluconobacter, Gluconacetobacter, and Komagataeibacter (Table 2) (Giudici, 84 
De Vero, & Gullo, 2017). In addition, the aforementioned genera contain many species while 85 
the remaining genera consist of only one or two (Yamada, 2016). Some genera are motile, 86 
having either peritrichous or polar flagella. The majority of species are catalase-positive and 87 
oxidase-negative, however, there are exceptions. Growth in the presence of 0.35% acetic acid 88 
has been used as a criterion; however, while members of the genera Acetobacter, 89 
Gluconobacter, Gluconacetobacter, and Komagataeibacter grow in the presence of 0.35% 90 
acetic acid, not all genera can e.g. Asaia. Acetic acid bacteria are typically considered to be 91 
mesophilic, with the optimum temperature for growth being around 30oC (Malimas et al., 92 
2017). At higher temperatures, growth reduces significantly, with none usually occurring above 93 
34oC (Saichana, Matsushita, Adachi, Frebort, & Frebortova, 2015). The mesophilic character 94 
of AAB, which require strict temperature control, poses a challenge for industrial application. 95 
However, thermotolerant strains that can grow at a temperature of up to 42oC have been 96 
identified (Saichana et al., 2015). It is noteworthy that the genera constituting the AAB are 97 
undergoing continuous revision and taxonomic changes and the reader is directed elsewhere 98 
for further information on this topic, such as Malimas et al. (2017). Acetic acid bacteria are 99 
notable for their direct oxidation of carbohydrates and sugar alcohols from which they 100 
accumulate large amounts of the corresponding oxidation products, gleaning metabolic energy 101 
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from the process. This so-called “oxidative fermentation” is a key metabolic characteristic in 102 
AAB and is carried out by membrane dehydrogenases and will be considered in greater detail 103 
in subsequent sections (Matsushita & Matsutani, 2016). 104 
Acetic acid bacteria have primarily been isolated from sugary, acidic and alcoholic habitats, 105 
materials such as flowers or fruits, or from the fermented foods which they inhabit, such as 106 
vinegar, beer, cider and cocoa pulp-bean mass. As AAB occur as symbionts of insects, this can 107 
be another isolation source (Mamlouk & Gullo, 2013). Typically, species of Gluconobacter 108 
are associated with carbohydrate-rich environments, whereas species of Acetobacter can be 109 
found in alcohol-enriched niches (Raspor & Goranovic, 2008). 110 
Nutrient media for the isolation and growth of AAB can vary, mainly in the types of carbon 111 
sources which are included, as strains from different environments or niches differ in their 112 
nutritional requirements (Table 3). For example, glucose yeast extract carbonate (GYC) 113 
medium is commonly used for the isolation and growth of strains originating from 114 
carbohydrate-rich environments. Calcium carbonate is added to buffer the acid production, 115 
with a zone of clearing being observed around colonies of AAB when grown on agar media to 116 
which it has been added. For the isolation and growth of strains originating from ethanol- and 117 
acetic acid-rich environments the use of media containing ethanol and acetic acid is 118 
recommended (e.g. acetic acid ethanol (AE) medium) (Gullo & Giudici, 2008). When isolating 119 
strains from environmental sources or matrices likely to contain other microorganisms, AAB 120 
can be selected for by reducing the pH of the growth medium to pH 4.4 and/or by adding 121 
antimicrobial agents such as cycloheximide for the inhibition of yeasts or penicillin to inhibit 122 
lactic acid bacteria (LAB) (De Vero, Gullo, & Giudici, 2017). Media which contain alternative 123 
carbon sources to glucose, such as mannitol or malt extract, are commonly used for isolating 124 
AAB e.g. yeast extract peptone mannitol (YPM) medium and malt yeast extract agar (MYA) 125 
medium (Mamlouk & Gullo, 2013). Deoxycholate mannitol sorbitol (DMS) agar, which 126 
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contains a number of carbon sources has been used for the selective isolation and enumeration 127 
of presumptive AAB, for example, from cocoa pulp-bean mass and lambic beer. A modified 128 
version (mDMS) containing lactic acid, acetic acid and ethanol is advisable for the isolation of 129 
a number of AAB species (Camu et al., 2008; De Roos, Verce, Aerts, Vandamme, & De Vuyst, 130 
2018a; Papalexandratou et al., 2013; Wieme et al., 2014).  131 
The capability to accurately identify microorganisms is indisputable, not only from the 132 
perspective of obtaining a basic understanding of the microorganism(s) being applied, 133 
(particularly where the properties and desired traits that different species of microorganism 134 
possess, or ideally should possess, can vary), but also from a food safety perspective. Many 135 
DNA-based methods have been used for the identification of AAB, both as single isolated 136 
strains and as members of complex food matrices, such as fermenting wine (Gonzalez, Hierro, 137 
Poblet, Mas, & Guillamon, 2005). More recently, as the number of described AAB species has 138 
risen taxonomically, in part as a consequence of the use of such molecular techniques, the 139 
requirement for higher resolution and better differentiation between species has increased, 140 
necessitating the development of, firstly, molecular targets with increasing resolving power, 141 
and secondly, non-DNA-based methods that are sensitive and rapid (Andrés-Barrao et al., 142 
2013). 143 
Early molecular methods focused on the 16S rRNA gene and included Restriction Fragment 144 
Length Polymorphism Analysis (RFLP) of the gene or PCR amplification and direct 145 
sequencing (Andrés-Barrao et al., 2017). RFLP was a fingerprinting method that allowed 146 
identification to the species level, but required the restriction pattern of a known species as a 147 
comparison for identification. Also, direct sequencing of the gene necessitates that the 148 
sequence of a known species has been deposited in a database and can be used similarly for 149 
comparison. In addition, due to the sequence of the 16S rRNA gene being highly conserved 150 
between some species, differentiation between such species is not always possible. Therefore, 151 
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RFLP of the spacer region between the 16S and 23S rRNA genes (internal transcribed spacer, 152 
ITS) has been used to provide such differentiation (Gonzalez & Mas, 2011). Intergenic regions 153 
are known to have higher variability than functional, protein-coding sequences, thus being able 154 
to resolve closely related species (Barry, Colleran, Glennon, Dunican, & Gannon, 1991). 155 
However, due to frequent variations and high divergences of intergenic sequences, even among 156 
strains of the same species, direct sequencing of the ITS was not useful for identification to 157 
species level (Ruiz, Poblet, Mas, & Guillamon, 2000). Nevertheless, the use of a polyphasic 158 
approach including the sequencing of both the 16S rRNA gene and the ITS region for use in 159 
phylogenetic analysis has enabled differentiation of closely related strains (Gonzalez & Mas, 160 
2011). Alternative loci such as the adhA gene, recA gene and tuf gene can be used for 161 
polygenetic studies, showing similar results to phylogenies prepared with 16S rRNA and ITS 162 
sequences (Greenberg et al., 2006; Trcek, 2005).  163 
Another method of phylogenetic analysis which has gained prominence is Multilocus Sequence 164 
Typing (MLST). This is based on the phylogenetic analysis of concatenated sequences from 165 
single-copy, ubiquitous, protein-coding genes, typically house-keeping genes, which evolve 166 
faster than rRNA. Construction of phylogenetic trees based on concatenated sequences of the 167 
housekeeping genes dnaK, rpoB and groEL, produced similar results to those obtained with 168 
the 16S rRNA gene and delineation of closely related species of the K. liquefaciens and K. 169 
xylinus groups. In addition, trees based solely on individual dnaK, groEL and rpoB sequences 170 
showed similar topology to that of the tree based on the concatenated sequence of the same 171 
genes (Cleenwerck, De Vos, & De Vuyst, 2010). An increasingly applied format of MLST is 172 
the use of whole-genome sequences (as opposed to only a few house-keeping genes) in the 173 
phylogenetic analysis. Here, all of the genes that are present in all isolated strains or species 174 
under investigation (i.e. the core genome) are concatenated and used to build the phylogenetic 175 
tree (Matsutani, Hirakawa, Yakushi, & Matsushita, 2011). 176 
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For genotyping and identification to the strain level, methods such as Random Amplification 177 
of Polymorphic DNA (RAPD) and Amplified Length Fragment Polymorphism (ALFP), and 178 
techniques based on amplification of repetitive sequences, such as Enterobacterial Repetitive 179 
Intergenic Consensus-PCR (ERIC-PCR), Repetitive Extragenic Palindromic-PCR (REP-PCR) 180 
and (GTG)5-PCR have been variously applied in studies, all of which are fingerprinting 181 
techniques. Both ERIC-PCR and (GTG)5-PCR have been demonstrated to be most suitable for 182 
the differentiation of isolates to strain level, in some studies being used to monitor the 183 
population dynamics of AAB in traditional wine vinegar production at the strain level (De 184 
Vuyst et al., 2008; Papalexandratou & De Vuyst, 2011; Vegas et al., 2010). 185 
Alternatives to DNA-dependant molecular methods are increasingly being explored as 186 
accurate, rapid and high throughput means of microbial identification. One such method is 187 
Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry (MALDI-188 
TOF MS) which has originally been exploited in the field of clinical microbiology for the rapid 189 
identification of human pathogens, but has in recent years developed in the area of food 190 
microbiology (Croxatto, Prod'hom, & Greub, 2012; De Roos, et al., 2018a; Spitaels et al., 191 
2014a; Spitaels et al., 2015). MALDI is a soft ionization method used with mass spectrometry 192 
for the analysis of large organic biomolecules. Briefly, the sample is bombarded with a high-193 
energy laser beam leading to ionization of the sample in the form of cations. These ions are 194 
then accelerated in an electric field to a speed that depends on the mass-to-charge (m/z) ratio 195 
of each specific particle produced upon sample ionisation. The particles then enter a TOF mass 196 
analyser and travel along a field-free flight path towards the detector. The time required for 197 
each particle to reach the detector is precisely measured and is dependent on its m/z ratio. The 198 
m/z ratio of each particle is determined and a mass spectrum is generated, representing both 199 
m/z and signal intensity of the detected ions. The mass spectrum generated from a bacterium 200 
corresponds to high-abundance soluble proteins, predominantly ribosomal proteins and other 201 
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abundant cytosolic proteins, and is unique to a bacterium because protein composition differs 202 
between different bacterial genera and species (Andrés-Barrao et al., 2017; Bourassa & Butler-203 
Wu, 2015). MALDI-TOF is comparable to 16S rRNA gene sequencing in its ability to 204 
differentiate to species level, as phylogenetic dendrograms produced by both methods were 205 
identical except for certain outlier strains which were positioned away from their expected 206 
taxonomic position on the tree (Andrés-Barrao et al., 2013). MALDI-TOF is not however 207 
suitable for differentiation at the strain level due to a strong effect of the growth medium used 208 
on the proteomic profile of the strains (Wieme et al., 2014). However, efforts to minimise the 209 
effect of the growth medium, with the potential to enable inter-strain discrimination, have been 210 
applied in some studies; for instance, sub-culturing of isolates under investigation multiple 211 
times on the same, defined agar medium prior to MALDI-TOF analysis (De Roos, et al., 2018a; 212 
Spitaels, Wieme, & Vandamme 2016).   213 
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Physiology and metabolism of AAB 214 
 Aerobic respiration 215 
Similar to many aerobic bacteria, AAB gain the majority of their energy by performing a type 216 
of aerobic respiration (Matsushita & Matsutani, 2016). In the general process of aerobic 217 
respiration, initially pyruvate is completely oxidised to carbon dioxide (CO2) in the citric acid 218 
cycle. Subsequently, the reduced electron acceptors formed in the citric acid cycle are shuttled 219 
to the respiratory chain in the cytoplasmic membrane. Here, oxidation of the reduced electron 220 
carriers by components of the respiratory chain (oxidative phosphorylation) results in the 221 
formation of water, along with exclusion of protons from the cytoplasm, producing a proton 222 
gradient. Equalisation of this proton-motive force via transfer of protons back into the cell 223 
through a transmembrane ATPase (F1F0-type ATP synthase) leads to the biosynthesis of energy 224 
in the form ATP (Madigan, Martinko, Bender, Buckley, & Stahl, 2015).  225 
The basic components of the AAB respiratory machinery consist of two periplasmic 226 
dehydrogenases: a membrane-bound proton pumping transhydrogenase, a non-proton 227 
translocating NADH: ubiquinone oxidoreductase, and two terminal oxidases of the ubiquinol 228 
oxidase-type. Ubiquinone (UQ) acts as the electron shuttle, in its reduced form, ubiquinol 229 
(UQH2), between these respiratory proteins. The function of the transhydrogenase and NADH: 230 
ubiquinone oxidoreductase is the regeneration of NADP+ and NAD+, respectively, with the 231 
concomitant exclusion of protons in the case of the transhydrogenase complex. The terminal 232 
oxidases accept the electrons from ubiquinone, transferring them to molecular oxygen, the final 233 
electron acceptor, forming water (Figure 1). AAB have two terminal ubiquinol oxidases, 234 
designated cytochrome bo3 ubiquinol oxidase and cytochrome bd quinol oxidase. Cytochrome 235 
bo3 ubiquinol oxidase catalyses a reaction which contributes to the generation of a proton-236 
motive force while cytochrome bd quinol oxidase does not. An important function of the latter 237 
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terminal oxidase is believed to be the re-oxidation of ubiquinol to ubiquinone, thus rapidly 238 
regenerating ubiquinone that can contribute to further reactions in the respiratory chain or in 239 
the reactions of oxidative fermentation. In addition, it has been found that, in G. oxydans, the 240 
cytochrome bd quinol oxidase is particularly active at low pH (Hanke et al., 2012). Thus, it is 241 
suggested that cytochrome bo3 oxidase may serve as a major terminal oxidase at the early 242 
growth phase, when the culture pH is closer to neutral, and when the pH is decreased as a result 243 
of the production of a large amount of oxidized products, cytochrome bd quinol oxidase 244 
maintains oxidative fermentation under acidic conditions by complementing the function of 245 
cytochrome bo3 oxidase (Miura et al., 2013). 246 
Compared to some microorganisms which obtain energy via respiration (e.g. Escherichia coli), 247 
the energy yield, and thus biomass yield, of AAB are relatively low (Luttik, Van Spanning, 248 
Schipper, Van Dijken, & Pronk, 1997). This can be attributed to the absence of certain key 249 
respiratory chain components in these microorganisms. For example, the genome of 250 
Gluconobacter oxydans 621H lacks genes encoding cytochrome c oxidase (complex IV; 251 
despite encoding genes for a cytochrome bc1 complex and for a soluble cytochrome c) and the 252 
proton-translocating NADH: ubiquinone oxidoreductase (complex I; G. oxydans has a non-253 
proton-translocating NADH: ubiquinone oxidoreductase instead) (Prust et al., 2005). Thus, G. 254 
oxydans lacks two components which would normally perform proton translocation leading to 255 
the generation of a proton-motive force. However, not all AAB are as deficient in their 256 
respiratory machinery, for example, A. pasteurianus 386B, a strain isolated from a spontaneous 257 
cocoa bean fermentation, encodes a complete proton-translocating complex I (Illeghems, De 258 
Vuyst, & Weckx, 2013). 259 
Therefore, due to the inadequate coupling of the electron transport with proton translocation, 260 
the proton-translocating potential and thus ability for energy transduction in G. oxydans is 261 
relatively limited. Thus, a low amount of energy is conserved by the microorganism, which 262 
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limits its growth rates, with most of the energy being lost as heat (Matsushita, Nagatani, 263 
Shinagawa, Adachi, & Ameyama, 1989). In this context, while appearing inefficient, and as 264 
will be discussed further below, the presence of membrane-bound (periplasmic) 265 
dehydrogenases in AAB enable rapid oxidation of substrates via “oxidative fermentation” at 266 
the cell membrane level, without the need for time-consuming intracellular transport; this 267 
generates the necessary proton-motive force and allows rapid energy conservation, in addition 268 
to generating an unfavourable environment for competing microorganisms through the 269 
production of acidic products of oxidation (Zahid, 2017). 270 
 271 
 Oxidative fermentation 272 
“Oxidative fermentation” is a process of incomplete oxidation of substrates which are oxidised 273 
by primary dehydrogenases of a respiratory chain, with the concomitant release of oxidised 274 
products into the surrounding medium. Bacteria capable of performing oxidative fermentation 275 
are termed “oxidative bacteria”. Acetic acid bacteria are most prominent of such bacteria and 276 
commonly oxidise ethanol, carbohydrates and sugar alcohols to the various corresponding 277 
products such as organic acids, aldehydes and ketones (Table 4) (Matsushita & Matsutani, 278 
2016). Oxidative fermentation can be considered as an “overflow metabolism”, from which 279 
lower amounts of energy are conserved compared to if the substrates were completely oxidised 280 
to CO2 and water by aerobic respiration (Deppenmeier & Ehrenreich, 2009). Examples of 281 
oxidative fermentation reactions include the conversion of ethanol to acetic acid (carried out 282 
by almost all genera of AAB and from where these bacteria get their name), and the conversion 283 
of glucose via glucono delta-lactone to gluconic acid/gluconate (GA), amongst others. Oxygen 284 
availability is of prime importance and profoundly affects the fermentation rate and 285 
productivity (Gullo, Verzelloni, & Canonico, 2014). The high accumulation of acidic products 286 
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in their environment give AAB an advantage over competitive microorganisms (Matsutani et 287 
al., 2014). 288 
Oxidative fermentation reactions are performed by respiratory chains in AAB that are similar 289 
to the respiratory chains discussed above that oxidise reduced electron carriers (i.e. 290 
nicotinamide adenine dinucleotide phosphate [NAD(P)]-dependent dehydrogenases) and 291 
reduce ubiquinone (Figure 1). That is, in the process, electrons are channelled by ubiquinone 292 
to molecular oxygen at terminal oxidases while protons are abstracted to create a proton-motive 293 
force. This proton-motive force could be used by ATP synthase, or to perform some other 294 
energetic work. However, the dehydrogenase enzymes in the respiratory chains involved in 295 
oxidative fermentations are enzymes which specifically oxidise substrates such as ethanol, 296 
carbohydrates and sugar alcohols (as opposed to reduced electron carriers such as NADH). 297 
These enzymes contain a prosthetic group and are typically either PQQ (pyrroloquinoline 298 
quinone)-dependent dehydrogenases (quinoproteins and quinoprotein-cytochrome c 299 
complexes) or FAD-dependent dehydrogenases (flavoprotein-cytochrome c complexes), some 300 
of which work on the same substrate but produce different oxidation products (Adachi et al., 301 
2003) (Table 4). MCD (methylsuccinyl-CoA dehydrogenase)-dependent dehydrogenases 302 
(molybdoprotein-cytochrome c complexes) have also been identified in some genera (Thurner, 303 
Vela, Thöny-Meyer, Meile, & Teuber, 1997). The cytochrome subunit of these dehydrogenases 304 
is responsible for the transfer of electrons to, and thus reduction of, ubiquinone to ubiquinol 305 
(Matsushita, Yakushi, Toyama, Shinagawa, & Adachi, 1996). In addition, these respiratory 306 
chains are located on the periplasmic face of the cytoplasmic membrane, while those involved 307 
in the oxidation of reduced electron carriers are located in the cytosol of the cell. The cytosolic 308 
NAD(P)-dependent dehydrogenases have no role in oxidative fermentation. Indeed, it appears 309 
that the cytosolic respiratory chain competes with the oxidative fermentation (periplasmic) 310 
respiratory chains regarding electron transfer and energetics and that both forms of respiration 311 
15 
 
occur in different growth phases (discussed further below) (Matsushita & Matsutani, 2016). 312 
Thirty-two membrane-bound dehydrogenases have been identified in the genome of G. 313 
oxydans 621H with 11 known and 21 unknown substrate specificities (Richhardt, Luchterhand, 314 
Bringer, Buchs, & Bott, 2013).  315 
 316 
Ethanol oxidation 317 
One of the most well-known and important oxidative fermentation reactions performed by 318 
AAB is the production of acetic acid (vinegar) from ethanol. Both Acetobacter and 319 
Komagataeibacter species have a strong ability to produce acetic acid and both genera also 320 
show high resistance to high ethanol and acetic acid levels, which are important traits for 321 
industrial vinegar production (Taban & Saichana, 2017). Ethanol oxidation is catalysed by two 322 
membrane-bound enzymes located on the outer surface of the cytoplasmic membrane 323 
(periplasmic side). Ethanol is first oxidized to acetaldehyde by a PQQ-dependent alcohol 324 
dehydrogenase (ADH) and acetaldehyde is further oxidized to acetic acid by aldehyde 325 
dehydrogenase (ALDH). The prosthetic group of ALDH has been shown to be different 326 
between genera, being either PQQ- or MCD-dependent (Gómez-Manzo et al., 2010; Thurner 327 
et al., 1997). ADH is stable over a broad pH range of 2.3 to 8.0 and retained more than 90% 328 
activity when incubated on ice for 30 minutes. ALDH, while also stable at acidic pHs (optimum 329 
pH 4 – 5, but can also function at lower pH values), is more heat stable than ADH, retaining 330 
more than 50% activity after 30 min at 60oC (Kanchanarach et al., 2010a). However, ALDH is 331 
sensitive to the level of oxygen present; when this is either too low or too high its activity falls, 332 
allowing acetaldehyde to accumulate in the medium (Mamlouk & Gullo, 2013; Rubio-333 
Fernandez, Desamparados Salvador, & Fregapane, 2004). 334 
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The ADH activity in Acetobacter species has been found to be more stable under acid 335 
conditions than that of Gluconobacter species, which may partly explain why acetobacters are 336 
more proficient in acetic acid production than gluconobacters and gluconacetobacters 337 
(Matsushita, Toyama, & Adachi, 1994). In addition, when G. oxydans is grown in media 338 
supplemented with a fixed amount of ethanol at the beginning, the levels of acetic acid 339 
produced by the strain are lower when glucose is present as a carbon source and GA is therefore 340 
produced; that is, acetic acid is still produced by G. oxydans, albeit at lower levels if glucose 341 
is available for GA production (authors own observations). 342 
Inactive forms of ADH have been identified from strains of Gluconobacter and 343 
Gluconacetobacter. Ethanol-oxidation-deficient strains of Gluconobacter have a single 344 
nucleotide polymorphism that results in a truncated signal peptide and therefore incorrect 345 
localisation of the protein in the cytoplasmic membrane. When these gluconobacters are grown 346 
in acidic or high aeration conditions, they produce a large amount of ADH protein, but ADH 347 
activity remains unchanged, suggesting the presence of an inactive protein. Such inactive ADH 348 
displays a tenth of the activity of the active form (Gomez-Manzo et al., 2012; Matsushita, 349 
Yakushi, Takaki, Toyama, & Adachi, 1995). Certain cultivation conditions such as low pH 350 
and/or high aeration also reduce ADH activity, such as in Gluconobacter suboxydans, where 351 
low aeration was shown to favour active over inactive ADH formation (Matsushita et al., 1995). 352 
ADH displays a wide specificity for short-chain alcohols, except methanol. Glycerol can be a 353 
substrate, yielding glyceraldehyde, but only under high concentrations does ADH oxidise 354 
glycerol at a significant rate. Aldehydes can also be oxidised by ADH, and in some AAB, at a 355 
similar rate to alcohols. This has led to the suggestion that ADH alone (and not in concert with 356 
ALDH) can perform the acetic acid fermentation, which has been shown for the strain Ga. 357 
diazotrophicus Pal5 (Gomez-Manzo et al., 2015).  358 
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When ethanol has been completely oxidised and depleted, some genera of AAB, namely 359 
Acetobacter, Gluconacetobacter and Komagataeibacter, can assimilate acetic acid and oxidise 360 
it completely to CO2 and water using the citric acid cycle and glyoxylate shunt, which is known 361 
as acetate “overoxidation” (Sievers & Swings, 2005). There also appears to be an irreversible 362 
metabolic change, after which they are unable to oxidize ethanol again; this is evidently 363 
unfavourable in vinegar production as it leads to lower acetic acid yields (Raspor & Goranovic, 364 
2008). Gluconobacter and some other AAB genera do not overoxidise acetate as they lack key 365 
enzymes in the citric acid cycle and glyoxylate shunt (Deppenmeier & Ehrenreich, 2009; 366 
Mamlouk & Gullo, 2013). Because of this difference in oxidative potential, gluconobacters are 367 
sometimes referred to as “under-oxidisers” and acetobacters (and gluconacetobacters) as “over-368 
oxidisers” (Bartowsky & Henschke, 2008). Overoxidation can be avoided if a small proportion 369 
of ethanol is maintained in the medium (Raspor & Goranovic, 2008).  370 
 371 
Oxidation of carbohydrates and carbon metabolism in Gluconobacter oxydans 372 
Catalysed by various periplasmic dehydrogenases involved in oxidative fermentation, AAB 373 
oxidise a number of carbohydrates to their corresponding carboxylic acids, obtaining metabolic 374 
energy in the process through the ultimate generation of a proton-motive force, as described 375 
above. As mentioned, while Acetobacter and Komagataeibacter are efficient at ethanol 376 
oxidation, Gluconobacter species are particularly proficient in carbohydrate and sugar alcohol 377 
oxidation (Matsushita & Matsutani, 2016). The production of GA and associated 378 
ketogluconates from glucose by Gluconobacter oxydans will be described below to illustrate 379 
carbohydrate oxidation in AAB, followed by a description of carbon metabolism in G. oxydans. 380 
Gluconic acid and its salts has wide application in various industries such as the food, 381 
construction, textile and pharmaceutical sectors (discussed further in the section 382 
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“Biotechnological applications of Gluconobacter oxydans relevant to the food industry”) and 383 
G. oxydans represents an alternative to the current use of the fungus Aspergillus niger as a 384 
source of GA (García-García et al., 2017). 385 
Acetic acid bacteria oxidise D-glucose firstly to D-glucono-δ-lactone by PQQ-dependent 386 
glucose dehydrogenase (PQQ-GDH) and then to D-gluconate, either spontaneously or via a 387 
gluconolactonase located in the cytoplasmic membrane (Raspor & Goranovic, 2008). D-388 
gluconate can be further converted to ketogluconates by other periplasmic dehydrogenases. It 389 
can be oxidised further to either 2-keto-D-gluconate (2KGA) by an FAD-containing gluconate 390 
dehydrogenase (FAD-GADH) or 5-keto-D-gluconate (5KGA) by PQQ-glycerol 391 
dehydrogenase (PQQ-GLDH). In some AAB strains, 2KGA is later converted to 2,5-diketo-392 
gluconate (2,5-diKGA) by FAD-containing 2KGA dehydrogenase (FAD-2KGADH) 393 
(Shinagawa, Ano, Yakushi, Adachi, & Matsushita, 2009; Toyama et al., 2007). Conversion of 394 
GA to its associated ketogluconates is both strain- and growth condition-dependent. Factors 395 
such as glucose concentration, pH and the level of oxygenation effect the yield and ratio of GA 396 
to ketogluconates (García-García et al., 2017; Saichana et al., 2015). It is clear that the further 397 
oxidation of GA to ketogluconates is undesirable if the production of D-gluconate is to be 398 
maximised (Mamlouk & Gullo, 2013); this will be discussed further in the section 399 
“Biotechnological applications of Gluconobacter oxydans relevant to the food industry”. 400 
When AAB are grown on alcohols, carbohydrates or sugar alcohols two growth phases 401 
(biphasic growth, phase I and II) can be observed (Malimas et al., 2017). In both phases, the 402 
majority of energy is obtained from respiratory chains and the generation of a proton-motive 403 
force; however, in the second growth phase some of the energy is obtained through assimilation 404 
and metabolic catabolism of the oxidised products produced in the first growth phase. In the 405 
case of glucose, for example, the early, logarithmic growth phase results from the energy 406 
derived from the oxidative fermentation of glucose, which produces gluconate and a small 407 
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amount of 2KGA, as described above. In the process, a proton-motive force is generated which 408 
drives ATP biosynthesis. When glucose is used up, the cells enter a stationary phase. However, 409 
a second growth phase is subsequently observed, which is primarily due to the further oxidation 410 
of gluconate to 2KGA. In both phases I and II a small proportion of gluconate is assimilated 411 
by the cells and is subsequently catabolised intracellularly in the reactions of primarily the 412 
Pentose Phosphate pathway (PPP), but the Entner Doudoroff pathway (EDP) and the citric acid 413 
cycle also have a role (Prust et al., 2005). These reactions yield additional energy primarily via 414 
the generation of reduced electron acceptors (e.g. NADH) which are subsequently oxidised by 415 
the cytosolic respiratory chains (NAD(P)-dependent dehydrogenases), thus generating a 416 
proton-motive force. Actually, only a small proportion of the glucose (phase I) and gluconate 417 
(phase II) are assimilated and catabolised intracellularly, the majority of the energy being 418 
yielded by oxidative fermentation reactions (Bringer & Bott, 2016). In this way, the cytosolic 419 
NAD(P)-dependent respiratory chains primarily have a role in the later phase of growth. 420 
Catabolism of GA and associated ketogluconate products is possible only via the PPP and EDP 421 
because AAB do not have the enzyme, phosphofructokinase, and thus glycolysis is not active. 422 
In addition, while most AAB genera can completely oxidise substrates to CO2 and H2O in the 423 
citric acid cycle, in Gluconobacter this cycle is incomplete as they lack the enzymes succinyl-424 
CoA synthetase and succinate dehydrogenase (Bringer & Bott, 2016).  425 
While the metabolism of intracellular, assimilated glucose and gluconate, primarily via 6-426 
phosphogluconate, may involve the PPP, EDP and citric acid cycle, the majority of energy 427 
gained from intracellular metabolism is derived from the oxidative PPP, whereas the EDP is 428 
dispensable. Carbon labelling of glucose has demonstrated the carbon flux during cellular 429 
metabolism of glucose in G. oxydans, showing that the majority of energy is derived from the 430 
PPP which operates in a cycle (Hanke et al., 2013). The key enzymes in the cycle are glucose-431 
6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase; deletion of 6-432 
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phosphogluconate dehydrogenase was observed to severely limit the growth of G. oxydans. In 433 
contrast, deletion of an integral enzyme in the EDP (2-keto-3-deoxy-6-phosphogluconate 434 
aldolase) had little effect on strain growth (Bringer & Bott, 2016; Hanke et al., 2013).  435 
The initial generation of oxidised products of carbohydrates and sugar alcohols allows AAB to 436 
rapidly deplete the availability of carbon sources for competing microorganisms, while also 437 
producing an inhibitory environment for such competitors due to the resulting low pH 438 
generated by the accumulation of the acidic products; in addition, the potential for these 439 
products to be assimilated and used partly as an energy source by AAB provides a further 440 
competitive advantage (García-García et al., 2017).    441 
 442 
 Tolerance to acidic environments 443 
Acetic acid is an effective antimicrobial compound, yet most species of AAB are able to 444 
produce and tolerate high concentrations, from 6 - 10% (v/v) and some up to 15 – 20% (v/v) 445 
(Emde, 2006; Schüller, Hertel, & Hammes, 2000). Halstead et al. (2015) found that acetic acid 446 
at concentrations from 5% to as low as 0.3% were capable of preventing growth of both 447 
planktonic cells and biofilms formed by a range of pathogenic microorganisms that typically 448 
affect burns patients, including Staphylococcus aureus, Escherichia coli, Pseudomonas 449 
aeruginosa and Acinetobacter baumannii. Gram-negative isolates were generally found to be 450 
more susceptible than Gram-positive strains (Halstead et al., 2015). This antibacterial efficacy 451 
raises the question as to how AAB can tolerate such high acetic acid levels. Different genera 452 
of AAB display varying tolerances to acetic acid; species of Acetobacter such as A. aceti and 453 
A. pasteurianus tolerate acidities of about 6 – 10%, while Komagataeibacter are generally more 454 
acid tolerant. Strains of K. xylinus and K. hansenii, for example, show resistance to 10 - 15% 455 
acetic acid, while strains of K. europaeus and K. oboediens, have been isolated from submerged 456 
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vinegar fermentation processes with acidities as high as 15 - 20% (Andrés-Barrao & Barja, 457 
2017; Emde, 2006). 458 
Acetic acid is a particularly effective antimicrobial, because at a relatively high pH (pH 4.7 = 459 
pKa of acetic acid) it exists primarily in its undissociated form and can enter the cell 460 
(Hirshfield, Terzulli, & O’Byrne, 2003). The properties of undissociated organic acids such as 461 
fat-solubility and neutral charge enable them to passively diffuse through the cell membrane 462 
of the target microorganism; in the cytoplasm the higher intracellular pH causes the acid to 463 
become dissociated, producing primarily hydrogen ions (H+), but also acetate ions (CH3COO
–464 
). These ions are toxic to the cell and interfere with cellular processes such as enzyme activity, 465 
DNA replication and transcription, and protein expression, therefore effecting the normal 466 
growth of the microorganism (Chen, Chen, Giudici, & Chen, 2016; Russell & Diez-Gonzalez, 467 
1997).  468 
AAB employ a number of strategies to resist the detrimental effects of acetic acid, which will 469 
be discussed briefly here. Readers are directed to Andrés-Barrao & Barja (2017) for a more in-470 
depth appraisal of the topic. The mechanisms which AAB use to tolerate high concentrations 471 
of acetic acid can be broadly classified as follows, 1) adaption of and protection of intracellular 472 
proteins to and against acid stress, 2) metabolism of acetic acid which enters the cell 473 
(overoxidation), 3) acetic acid efflux from the cell and 4) prevention of acetic acid from 474 
entering the cell (Figure 3).  475 
Many intracellular proteins of AAB have adapted to tolerate a low cytoplasmic pH. For 476 
example, certain enzymes in particularly acid tolerant AAB (e.g. A. pasteurianus) have 477 
structural modifications, such as a higher number of inter-subunit hydrogen bonds and an 478 
increased number of arginine-containing salt bridges that not only confer stability in the acidic 479 
cytoplasm of AAB, but may also contribute to thermotolerance (Settembre, Chittuluru, Mill, 480 
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Kappock, & Ealick, 2004). The heat-shock systems, GroESL and DnaJK, are also important in 481 
acetic acid resistance. These chaperones and chaperonins are general stress proteins that protect 482 
other proteins from denaturation and aggregation caused by heat, but also other environmental 483 
stresses such as oxidative, acid, salt, and starvation stresses (Andrés-Barrao & Barja, 2017). 484 
Under both [sudden] acid-shock conditions, induced through the addition of 3% acetic acid to 485 
a growing culture, and more continuous stress conditions in the presence of high ethanol and 486 
increasing acetic acid levels (e.g. conditions which occur during vinegar fermentation), 487 
increased protein expression of the chaperone system consisting of GroESL, DnaKJ and GrpE 488 
occurs (Andrés-Barrao et al., 2012; Matsushita et al., 1994). In addition, disruption of RpoH, 489 
an important RNA polymerase sigma factor in the regulation of the heat-shock response 490 
proteins such as GroEL, DnaK, DnaJ, resulted in reduced expression of concomitant genes and 491 
decreased resistance to ethanol (5%) and acetic acid (1%) stress conditions in a strain of A. 492 
pasteurianus (Okamoto-Kainuma et al., 2011). 493 
As described above, when ethanol has been completely oxidised and depleted, some genera of 494 
AAB assimilate acetic acid and oxidise it completely to CO2 and water using the citric acid 495 
cycle and glyoxylate shunt (acetate “overoxidation”) (Sievers & Swings, 2005). Thus, 496 
overoxidation is a mechanism by which the intracellular acetic acid level can be decreased, 497 
whilst also gleaning energy from the process through the oxidative reactions of the citric acid 498 
cycle. In addition, acetic acid may be assimilated from the environment causing the pH to rise. 499 
In both cases, the effect is essentially a detoxification of acetic acid and reduced acid stress on 500 
the bacterium. A fully functioning citric acid cycle is necessary for acetic acid overoxidation, 501 
which has been found to be the case for the most acid tolerant AAB such as Acetobacter and 502 
Komagataeibacter; other genera such as Gluconobacter do not possess a complete citric acid 503 
cycle which maybe an important factor in explaining their comparatively lower tolerance to 504 
acetic acid (Mamlouk & Gullo, 2013; Prust et al., 2005). In addition, this lower acid tolerance 505 
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may be linked to the reduced acetic acid productivity of Gluconobacter strains compared to 506 
those of Acetobacter and Komagataeibacter, which are commonly used in industrial vinegar 507 
production. In those AAB capable of overoxidation, a number of genes involved in the citric 508 
acid cycle and glyoxylate shunt are up-regulated during acetic acid fermentation, primarily at 509 
the end of ethanol oxidation. These include aarA (encoding for a citrate synthase), aarC 510 
(encoding for a succinyl CoA:acetate CoA-transferase) and aconitase (isomerises citrate) 511 
(Sakurai, Arai, Ishii, & Igarashi, 2012). It is noteworthy that during vinegar fermentation, it is 512 
desirable to maintain a low level of residual ethanol, to avoid the overoxidation of acetic acid 513 
which would lead to productivity losses. Therefore, in this case, acetic acid cannot be detoxified 514 
by this mechanism and other strategies must be employed to maintain acetic acid tolerance 515 
(Andrés-Barrao & Barja, 2017). 516 
The export of intracellular acetate is another strategy employed by AAB to tolerate acetic acid. 517 
Two types of export systems have been identified, an efflux pump driven by a proton-motive 518 
force (anti-port of H+ ions) and an ATP-binding cassette (ABC) transporter (Matsushita, Inoue, 519 
Adachi, & Toyama, 2005; Nakano, Fukaya, & Horinouchi, 2006). This ABC transporter has 520 
been found in Acetobacter and Komagataeibacter species and confers resistance to acetic acid, 521 
in addition to other short-chain organic acids such as formic acid, propionic acid and lactic acid 522 
(Nakano & Fukaya, 2008). Export of acetic acid may play a crucial role in cell survival under 523 
the high acidity conditions prevailing during the industrial production of vinegar, because, as 524 
mentioned above, under these conditions assimilation of acetate via the citric acid cycle is 525 
prevented in order to maintain acetic acid productivity. 526 
Another strategy used by AAB to resist acid stress is the exclusion of acetic acid and its 527 
prevention from entering the cell. To this end, certain species, for example those of the genus 528 
Komagataeibacter, are reported to have a higher content of phosphatidylcholine (PC) in their 529 
lipid membranes (Nakano & Ebisuya, 2016). In addition, during acetic acid fermentation, as 530 
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the acid content began to rise, the ratio of PC was observed to increase and that of 531 
phosphatidylglycerol decreased, suggesting the importance of PC in acetic acid tolerance 532 
(Higashide et al., 1996). The cell membranes of Komagataeibacter have also been found to 533 
possess a high content of hopanoids, especially tetrahydoxybacteriohopane (THBH), which 534 
may have a role in acetic acid, but also ethanol, tolerance (Nakano & Ebisuya, 2016). 535 
Carbohydrate polymers attached to the outer membrane may also play a role in protecting 536 
against acetic acid ingress into the cell. The intracellular content of acetate was found to be 537 
significantly higher in a strain of A. pasteurianus displaying a non-polysaccharide-producing 538 
phenotype, compared to a polysaccharide-producing strain (Kanchanarach et al., 2010b).  539 
Finally, it is noteworthy that there appears to be a link between acetic acid resistance and the 540 
yield or productivity during acetic acid fermentation. During investigations into the 541 
mechanisms of acetic acid resistance, strains which were modified to overexpress certain genes 542 
involved in acetic acid resistance, namely, aconitase, an enzyme in the citric acid cycle 543 
(Nakano, Fukaya, & Horinouchi, 2004) or AatA, the putative ABC transporter involved in 544 
acetic acid export (Nakano et al., 2006), not only displayed increased resistance to acetic acid 545 
but also produced higher acetic acid yields. Thus, the higher acetic acid productivity of 546 
Komagataeibacter and Acetobacter species may partly be a consequence of their natural 547 
intrinsic tolerance to acetic acid, when compared to species such as Gluconobacter, which in 548 
general, display lower acetic acid productivity.  549 
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Cellulose and other exopolysaccharides produced by AAB 550 
Cellulose is the most abundant natural polymer on the planet, with high economic value. Plants 551 
(e.g. wood and cotton) and ocean phytoplankton and algae are nature’s largest source of 552 
cellulose (Tonouchi, 2016). Certain bacteria, most notably AAB of the genus 553 
Komagataeibacter (formerly Gluconacetobacter), are capable of producing large amounts of 554 
cellulose (Lin et al., 2013). The chemical structure of plant and bacterial cellulose (BC) is 555 
identical, that is, composed of β-1,4-linked glucopyranosyl residues; however, the structure of 556 
BC is unique as it is composed of ultrafine fibres that form a network of pure cellulose 557 
(Tonouchi, 2016). BC can also be known as bacterial nanocellulose (Klemm et al., 2011). BC 558 
is a linear, unbranched, water-insoluble homoexopolysaccharide of exceptionally high purity 559 
and containing no contaminating substances, in contrast to plant cellulose which contains lignin 560 
and hemicellulose (arabinoxylan), which can be tightly bound and complexed with cellulose. 561 
Therefore, high amounts of energy are required for the purification of plant cellulose, which is 562 
not the case for BC. In addition, BC exhibits high crystallinity, water absorption, tensile 563 
strength and mechanical strength (Mohite & Patil, 2014a). These properties make it a 564 
favourable alternative to plant cellulose. 565 
Several species of AAB within the genera Acetobacter, Gluconacetobacter, Gluconobacter and 566 
Komagataeibacter produce cellulose. However, only Komagataeibacter produce it at 567 
commercial levels, with K. xylinus and K. hansenii being most notable (Lin et al., 2013). BC-568 
producing strains have been isolated from a number of environments, including fruits, flowers, 569 
fermented foods (e.g. vinegar) and beverages. 570 
The ecological benefit of cellulose production for AAB is not fully clear. It is commonly 571 
understood that its production forms a scaffold which floats on the liquid surface, as seen 572 
particularly in static cultures, allowing the bacteria access to both nutrients in the medium and 573 
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sufficiently high levels of oxygen in the air, required for their oxidative metabolism (Tonouchi, 574 
2016). As described above, EPS production may contribute to acetic acid tolerance. In addition, 575 
in natural environments such as rotting fruit, cellulose production may protect the bacteria from 576 
predation or from the damaging effects of UV light or dissection through moisture loss. 577 
Cellulose production appears to be variable in G. oxydans, with some strains capable of 578 
producing it having been identified previously (Jia et al., 2004; Valera, Torija, Mas, & Mateo, 579 
2015). In a screening of 77 different AAB strains, representing 35 different species, Valera et 580 
al. (2015) found that of the three G. oxydans strains examined, two produced cellulose on all 581 
the six different media used to investigate its production. Both of these strains were isolates 582 
from beer (Valera et al., 2015). However, yields of cellulose from G. oxydans are much lower 583 
than those of Acetobacter xylinum (presently K. xylinus) (Jia et al., 2004). This could be due to 584 
the fact that in AAB, both cellulose production and glucose oxidation (to GA and 585 
ketogluconates) are in competition for the same glucose as substrate. Thus, in G. oxydans, 586 
which has a particularly high oxidative capacity for carbohydrates, the majority of glucose may 587 
be oxidised to GA, resulting in low availability for cellulose production. In contrast, K. xylinus 588 
may utilise the majority of glucose for cellulose production (De Muynck et al., 2007). Indeed, 589 
Keshk and Sameshima (2006) demonstrated that productivity of BC from Ga. xylinus (now K. 590 
xylinus) increased significantly in the presence of lignosulfonate, an antioxidant compound that 591 
inhibited the formation of GA. In its presence, one strain of Ga. xylinus produced up to 16 g/L 592 
BC (Keshk & Sameshima, 2006). A similar effect was also observed in the presence of Vitamin 593 
C, which is also an antioxidant compound (Keshk, 2014). 594 
BC is synthesised from a variety of carbohydrates and organic acids by AAB (Serrato et al., 595 
2013). The cellulose biosynthesis pathway can be considered as an off-shoot of the PPP. 596 
Glucose is the polymeric unit that cellulose is composed of, therefore, other substrates must be 597 
converted to glucose-6-phosphate, a key intermediate, through various intracellular metabolic 598 
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reactions. Cellulose biosynthesis is comparable to that of heteropolysaccharides in other 599 
bacteria, such as LAB, the building block of which are sugar nucleotides (Lynch, Zannini, 600 
Coffey, & Arendt, 2018a). In the cellulose biosynthesis pathway, glucose-6-phosphate is 601 
converted to glucose-1-phosphate, which is subsequently metabolised to uridine 602 
diphosphoglucose (UDP-glucose), the direct precursor of cellulose. Uridine diphosphoglucose 603 
biosynthesis is controlled by phosphoglucomutase and UDPG-pyrophosphorylase. Following 604 
UDP-glucose formation, glucose polymerisation to produce cellulose is mediated by cellulose 605 
synthase, a complex of proteins spanning the periplasmic space between the cytoplasmic and 606 
outer membranes. The cellulose synthase complex facilitates the polymerisation of UDP-607 
glucose, translocation of the polymer across the membranes and assembly of the glucan chains 608 
extracellularly (Tonouchi, 2016). The protein subunits that constitute the cellulose synthase 609 
complex are encoded in an operon (the bcs operon), together with accessory proteins that assist 610 
cellulose biosynthesis. Following polymerisation of the individual β-1,4-glucan chains, these 611 
are brought together in a hierarchical manner to form the higher-order cellulose ribbon. In this 612 
way, several glucan chains form a ~1.5 nm wide protofibril, protofibrils are arranged into ~2-613 
4 nm microfibrils; finally, microfibrils are bundled together forming a ~20-100 nm cellulose 614 
ribbon (Jozala et al., 2016). In general, a single ribbon or fibre is produced by a bacterial cell, 615 
from BC synthase complexes (sometimes termed terminal complexes) that are arranged on one 616 
side of the cell only (Kimura, Chen, Saxena, Brown, & Itoh, 2001). This ribbon is ultrafine, 617 
being about one thousandth the width of a plant cellulose fibre (Tonouchi, 2016). As mentioned 618 
above, carbon sources other than glucose can be used for BC biosynthesis, however, besides 619 
mannitol and arabitol, all other sources result in lower BC productivity than on glucose 620 
(Khajavi, Esfahani, & Sattari, 2011).  621 
Aside from the carbon source, the nitrogen source and level of other micronutrients influence 622 
the growth of microorganisms as well as the productivity of BC (Dağbağlı & Göksungur, 623 
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2017). A number of agro-industrial waste by-products have been investigated for use in BC 624 
production, particularly those high in sucrose, fructose, nitrogen and vitamins (Castro et al., 625 
2011). 626 
Apart from the substrate material affecting yield, the method of production (e.g. static vs. 627 
stirred culture) can influence the structure and fibre network arrangement of the BC produced, 628 
thus having an effect on its physical and mechanical properties. Under static conditions, 629 
bacterial cellulose is produced in a gelatinous form. However, under agitation, shear stress 630 
seems to inhibit gel formation, resulting in the production of small aggregates, or in some cases, 631 
distinctive spheres of BC (Mohite & Patil, 2014b). In addition, in agitated cultures the fibrous 632 
network of BC is more disordered due to the physical effects of agitation (Watanabe, Tabuchi, 633 
Morinaga, & Yoshinaga, 1998). A negative effect of agitation is that it can induce mutations 634 
in certain strains, resulting in decreased BC production (Krystynowicz et al., 2002). Therefore, 635 
both the nature of the substrate material (carbon, nitrogen, micronutrient composition and 636 
concentration) and the method of production (static or stirred culture, type of bioreactor) are 637 
factors which contribute to the productivity and yield of BC. 638 
Due to physicochemical properties such as structure-forming potential, high purity and bio-639 
compatibility, BC has numerous potential applications, for example in the medical (e.g. as an 640 
artificial skin) and food industries (Tonouchi, 2016). Due to the scope of this review, only those 641 
applications relevant to the food industry will be described briefly below. Many current 642 
applications continue to employ plant-derived cellulose and it is used in food as a thickening, 643 
gelling, stabilising or water-binding agent (Shi, Zhang, Phillips, & Yang, 2014). For example, 644 
cellulose and its derivatives (known in the food industry as cellulosics) such as 645 
carboxymethylcellulose (CMC) and hydroxypropylmethylcellulose (HPMC) are important in 646 
the ice-cream and bakery industries, being used as a stabilising agent and a texture-modifying 647 
hydrocolloid, respectively (Murray, 2009). In particular, in gluten-free bread making, the use 648 
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of HPMC can increase moisture retention, increase loaf volume and decrease crumb hardness 649 
and the rate of staling (Mir, Shah, Naik, & Zargar, 2016). BC has functionality in areas where 650 
plant cellulose is limited. This is particularly attributed to the high purity, crystalline structure 651 
and high water-binding capacity of BC. Thus, it is recommended where low use levels, foam 652 
stabilisation, and stability over a wide range of pH, temperature and freeze-thaw conditions are 653 
desirable. Such products in which it has potential use include pourable and spoonable dressings, 654 
whipped toppings and aerated desserts, fermented and frozen dairy products, and sauces (Park 655 
& Khan, 2009). As a raw material, BC is a distinct constituent of Nata and kombucha tea. Nata 656 
is a BC gel, consumed as a desert in the Philippines, but becoming more popular worldwide. It 657 
is produced by fermenting coconut water (Nata de Coco) or pineapple juice (Nata de Piña) as 658 
a substrate with cellulose-producing AAB. The cellulose gel produced is cut into pieces and 659 
consumed, having the flavour of the original substrate (Shi et al., 2014). Kombucha tea is 660 
produced by fermenting sweetened tea with a symbiotic culture of bacteria and yeast (SCOBY) 661 
or “tea fungus”, of which cellulose-producing AAB constitute important members and produce 662 
a characteristic cellulose pellicle on the surface of the medium (De Roos & De Vuyst, 2018a). 663 
This pellicle harbours the community of bacteria and yeast which ferment the tea, producing a 664 
mildly acidic beverage. Kombucha tea is discussed further below. 665 
 666 
Acetan 667 
Acetan is formed by cellulose-producing AAB and is composed of a cellulose backbone, 668 
substituted on alternate glucose residues with a charged pentasaccharide side chain. This side 669 
chain is composed of D-glucose, D-mannose, L-rhamnose and D-glucuronic acid (Dağbağlı & 670 
Göksungur, 2017). Acetan biosynthesis is similar to that of heteropolysaccharides in other 671 
bacteria, consisting of formation of a lipid-linked oligosaccharide intracellularly followed by 672 
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polymerisation in the periplasmic space and export and release extracellularly (Tonouchi, 673 
2016). Production of acetan appears to affect cellulose biosynthesis as mutant acetan-non-674 
producing strains produce a cellulose that differs in its structure and crystallinity (Watanabe et 675 
al., 1998). Acetan has reportedly been widely used in various industries as a viscosifier and 676 
emulsifier; however, it is not listed in the current European regulation on food additives 677 
(European Commission, 2008; Ishida, Sugano, & Shoda, 2002).  678 
 679 
Levan 680 
Levan is a homoexopolysaccharide composed of fructose units (i.e. a fructan) linked via β-2,6 681 
glycosidic bonds. It is one of two types of fructans, the other being inulin (a β-2,1 linked 682 
fructan) (Monsan et al., 2001). Among the AAB, strains from the genera Gluconobacter, 683 
Komagataeibacter, Kozakia and Neoasaia are known to produce levan (Dağbağlı & 684 
Göksungur, 2017; Jakob et al., 2013). Levan is biosynthesised by an extracellular enzyme, 685 
known as levansucrase (a fructosyltransferase) secreted by the bacterium and using sucrose as 686 
a substrate (Srikanth, Reddy, Siddartha, Ramaiah, & Uppuluri, 2015). Jakob et al. (2012) 687 
screened 21 strains of AAB, representing 5 different genera for their ability to produce EPS on 688 
sucrose-based media. Of the strains investigated, only those in the genera Gluconobacter, 689 
Neoasaia, and Kozakia were shown to produce EPS of the levan type. A yield of 12 g/L was 690 
obtained from a strain of Gluconobacter frateurii (Jakob, Steger, & Vogel, 2012). Levan, due 691 
to its hydrocolloid properties, has potential applications in the food industry, for example, as 692 
an emulsifier, stabiliser, texture modifier or fat substitute. EPSs, including levan, have 693 
particularly been exploited in the bakery industry, and, through their application with 694 
sourdough technology, represent a natural alternative to commercial hydrocolloids for the 695 
enhancement of both conventional wheat-containing baked goods and gluten-free products 696 
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(Lynch, Coffey, & Arendt, 2018b). To date, EPS-producing strains of LAB have mainly been 697 
investigated for such application, but, in recent years AAB have become of increasing interest 698 
in this area (Jakob et al., 2012). Application by Jakob et al. (2012) of purified levan (1 - 2% 699 
w/w) from AAB to a wheat bread system increased the bread volume, softened the crumb and 700 
retarded staling (Jakob et al., 2012). Furthermore, in sucrose-supplemented spelt dough, a strain 701 
of Kozakia baliensis has been shown to produce up to 49 g/kg (of flour) EPS, followed by 33 702 
g/kg in whole wheat, and 32–36 g/kg in wheat and rye doughs (Hermann, Petermeier, & Vogel, 703 
2015). Ua-Arak et al. (2016) also demonstrated their potential for in-situ application and ability 704 
to grow and produce EPS in a gluten-free (buckwheat) sourdough system, with levan 705 
productivity of between 16 and 20 g/kg, in molasses-supplemented flour (Ua-Arak, Jakob, & 706 
Vogel, 2016). In a later study, the application of this sourdough improved the bread sensory 707 
and quality parameters, which included increasing specific volume and increasing crumb 708 
softness. However, the positive effects of sourdough application were masked by the impact of 709 
the natural acidification during fermentation. Thus, while the ability of AAB to produce a large 710 
quantity of high molecular mass levan is attractive and shows potential in bakery applications, 711 
a challenge remains due to the necessity for high levels of oxygen for growth during in-situ 712 
sourdough fermentation, coupled with the strong acidification (Ua-Arak, Jakob, & Vogel, 713 
2017). 714 
 715 
Dextran 716 
Dextran is a homoexopolysaccharide composed of glucose units (i.e. a glucan) linked via α-717 
1,6 glycosidic bonds (at least 50%) and variable amounts of α-1,4, α-1,3 and α-1,2 linkages, 718 
with or without branching. Dextrans are principally produced by species of LAB such as 719 
Leuconostoc, which use sucrose as a substrate (Monsan et al., 2001). The enzyme which 720 
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mediates the production of dextran in LAB is known as a dextransucrase (Lynch et al. 2018a). 721 
Many strains of G. oxydans produce dextran using a similar enzyme, known as dextran 722 
dextrinase. However, instead of sucrose, dextran dextrinase uses maltodextrins (α-1,4 glucan) 723 
as the substrate for dextran formation. Dextran cannot be produced from un-hydrolysed starch 724 
however. This has led to the suggestion that dextran dextrinase can act on the non-reducing 725 
ends of linear α-1,4 chain structures, but not on structures close to branch points in starch 726 
(Naessens, Cerdobbel, Soetaert, & Vandamme, 2005). G. oxydans appears to produce both an 727 
intracellullar and extracellullular dextran dextrinase, the extracellular form of which is 728 
particularly high in the presence of hydrolysed starch and maltodextrins. However, it was 729 
previously unclear whether these two forms of the enzyme were in fact the same enzyme, and 730 
whether the strain is stimulated to simply secrete the intracellular dextran dextrinase when 731 
hydrolysed starch and maltodextrins are present in the environment (Naessens et al., 2005). 732 
Recently, both forms of the enzyme were indeed shown to be identical (Sadahiro, Mori, Saburi, 733 
Okuyama, & Kimura, 2015). Compared to commercial dextran of a similar molecular mass 734 
produced by Leuconostoc mesenteroides, dextran produced by G. oxydans has a higher degree 735 
of branching and displays lower viscosity. Therefore, the latter may be more suitable for food 736 
applications not requiring a thickening functionality such as use as a dietary fibre or as a low-737 
calorie bulking agent (Naessens et al., 2005).  738 
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Vinegar fermentation 739 
Legal definition of vinegar  740 
The definition of vinegar itself varies from country to country and production is regulated by 741 
different laws (Table 5). “Vinegar” primarily is defined as a liquid product produced by the 742 
fermentation of carbohydrate sources and must contain a minimum of 3.75 to 5% (w/v) acetic 743 
acid. Based on the different laws on vinegar, the unifying parameters for its classification are 744 
the acidity, level of residual ethanol and their ratio to one another.  745 
 746 
 History of vinegar  747 
The history of vinegar production, which dates back more than 10,000 years (Johnston & Gaas, 748 
2006) represents a keystone example of microbial biotransformation. Vinegar, from the French 749 
word, vinaigre, meaning “sour wine” that in turn came from the Latin, vinum acetum, “wine 750 
vinegar” has always been considered the “poor relation” among fermented foods: it is not 751 
considered a “food”, nor does it have high nutritional value, and it is made through the 752 
biotransformation of richer, more nutritive products. Vinegar can be produced using almost 753 
anything that is a source of fermentable carbohydrate, including wine, molasses, beer, various 754 
fruits, honey or whey (Johnston & Gaas, 2006). Hippocrates of Kos (460-377 BC), father of 755 
modern medicine, recommended vinegar as a treatment for a number of diseases including the 756 
common cold and cough (Food: A Culinary History, 2000) and for the treatment of sores 757 
(Johnston & Gaas, 2006). The great military leader, Hannibal of Carthage (c. 200 BC) 758 
reportedly used vinegar to dissolve rocks that blocked his army's path over the Alps. Pliny the 759 
Elder (AD 23-79), recounts that the Egyptian Queen, Cleopatra (c. 50 BC) made a bet with the 760 
Roman general Mark Anthony that she could host the most expensive banquet costing ten 761 
million sesterces. He laughed at her, but during the meal, for the desert, she had a bowl of 762 
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strong vinegar brought in and dissolved a pearl of inestimable value in it, and then drank the 763 
resulting potion (Mazza & Murooka, 2009). In the 8th century, Samurai warriors of Japan used 764 
vinegar as a tonic, believing that it gave them power and strength (Ho et al., 2017). The study 765 
of its medical properties and its use was widespread in the Middle Ages, becoming a common 766 
remedy. During the Great Plague in the fourteenth century in France, vinegar was used to offer 767 
protection against the bubonic plague. In England, to prevent the spread of plague during the 768 
1660s money was deposited in troughs of vinegar in order to disinfect the coins (Solieri & 769 
Giudici, 2009).  A chronicle recounts that a concoction made from vinegar, garlic, mint and 770 
other herbs, supposedly invented by thieves, allowed them to rob the houses of plague victims 771 
without contracting the disease themselves. Fittingly, the mixture was called “Four Thieves 772 
Vinegar” and is still manufactured today, mainly in France (Mazza & Murooka, 2009). 773 
Through the centuries, from the beginnings of agriculture until today, vinegar has been 774 
employed by every culture in some form; as a condiment, as a pickling or preserving agent, as 775 
a disinfectant and cleansing agent and as a beverage. 776 
 777 
Fermentative processes in vinegar production  778 
Following the international definition of vinegar, in this review only vinegars derived from 779 
alcoholic and subsequent acetous fermentation processes of agriculturally-produced raw 780 
materials are considered. In Table 6 a list of vinegars is presented, but cannot be considered 781 
exhaustive because of the countless varieties produced worldwide. The diversity of raw 782 
materials used in the production of vinegar is very broad, ranging from by-products and 783 
agricultural surpluses to high quality substrates for the most prized vinegars, such as Aceto 784 
Balsamico Tradizionale (Italy) and Vinagre de Jerez (Spain). In Mediterranean countries, wine 785 
vinegar is unquestionably the most common type of vinegar. In general, fruit vinegars are 786 
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common in Europe while cereal vinegars are more common in China and Japan (Lu et al., 787 
2017). However, worldwide, most of the vinegar produced is “white” vinegar, made from 788 
diluted alcohol (Table 6). 789 
Even though the raw materials and end products of vinegar fermentation are diverse, the actual 790 
production processes are similar. In general, there are two fermentation steps involved in the 791 
vinegar production, which are alcoholic and acetous fermentation, as depicted in Figure 3. 792 
During production, ethanol formed by yeast, during fermentation under anaerobic conditions, 793 
normally by strains of Saccharomyces cerevisiae, is converted to acetic acid (acetification) by 794 
AAB, mainly members of the genus Acetobacter and Gluconacetobacter (now mainly 795 
Komagataeibacter) under aerobic conditions (Budak, Aykin, Seydim, Greene, & Guzel-796 
Seydim, 2014). However, other microorganisms, such as fungi and LAB, may be involved in 797 
certain vinegar types. Besides S. cerevisiae, other yeast species ubiquitously found on fruit and 798 
vegetables may play a role in vinegars produced from these substrates; the lactose-fermenting 799 
yeast, Kluyveromyces marxianus, is responsible for whey fermentation (Parrondo, Garcia, & 800 
Diaz, 2009). A complex association of yeasts, AAB and LAB is involved in the fermentation 801 
of kombucha and cocoa pulp-bean mass. It is probable that numerous AAB species involved 802 
in vinegar fermentation have yet to be described because of the difficulties associated with their 803 
cultivation on laboratory media (Cleenwerck & De Vos, 2008; Rainieri & Zambonelli, 2009). 804 
Depending on the rate of acetic acid formation during vinegar production, the acetous 805 
fermentation can be separated into two types of process: The Orléans method (slow) and the 806 
submerged and generator methods (quick). 807 
The Orléans method, also called “mother of vinegar system” or French method is one of the 808 
oldest techniques for producing vinegar, and is an example of a surface fermentation method. 809 
Historically, Orléans was a big port on the longest French river, the Loire. Wines arriving there 810 
from all regions of France often suffered during transportation, turning sour en route. These 811 
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wines were sold to the vinegar brewers of Orléans, instead of being sent to Paris, their 812 
destination (Bourgeois & Barja, 2009). In the Orléans process, acetification of ethanol into 813 
acetic acid is started by “seed vinegar”, or “mother of vinegar”, an undefined starter culture 814 
obtained from the previous vinegar fermentation.  This process is called backslopping. This 815 
procedure promotes the initial number of desirable microorganisms (yeasts and AAB) over the 816 
indigenous population (De Vuyst, 2000). The acetification is performed by a static culture of 817 
AAB that grow at the interface between the liquid and air where the oxygen concentration is 818 
high (Sengun, 2015). In order to facilitate the oxidation of the ethanol and to leave an air 819 
chamber, barrels are filled to approximately two-thirds their capacity and side holes enable 820 
circulation. A funnel extends to the base allowing wine to be added at the bottom of the barrel, 821 
and preventing disruption of the “mother of vinegar” biofilm of AAB that forms on the liquid 822 
surface (Mas, Torija, García-Parrilla, & Troncoso, 2014). During the first week acetous 823 
fermentation is activated, after which the liquid is transferred to another vessel. Acetous 824 
fermentation is slow, occurring primarily on the surface of the liquid, where there is sufficient 825 
oxygen to facilitate the conversion of ethanol to acetic acid. As the substrate ferments, the 826 
changed environmental conditions (e.g. reduced pH) favour the most competitive indigenous 827 
microbiota, and the more stringent the growth conditions, the greater the selective pressure. 828 
Acetous fermentation continues for between 8 and 14 weeks depending on various factors, 829 
including the initial composition of the substrate and alcoholic solution, the nature of the 830 
microorganisms present, the sufficiency of oxygen supplied and the fermentation temperature 831 
(Dabija & Hatnean, 2014). This slow fermentation is difficult to control, with a high risk of 832 
spoilage, and is now suitable only for small-scale production. A microbial succession occurs, 833 
as in many spontaneous fermentations, in which LAB and yeasts often dominate initially. These 834 
consume carbohydrates and produce lactic acid and ethanol, respectively, which inhibit many 835 
spoilage microorganisms, extending the shelf life of the resulting product. Acidity reaches a 836 
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maximum level after approximately three months. Vinegars produced by this slow, traditional 837 
method are considered of high quality due to their organoleptic complexity. The complexity 838 
and the resulting product quality are strongly influenced by (i) the substrate raw material and 839 
its preparation, (ii) the metabolism of the AAB, which produce additional products of oxidation 840 
and some ester compounds besides acetic acid, (iii) the interaction between the vinegar and the 841 
wood of the barrels, and (iv) the aging process, which incorporates all the aforementioned 842 
characteristics (Mas et al., 2014).  843 
Other surface fermentation methods such as the trickling (or quick vinegar) generator processes 844 
(of which the Schutzenbach system or German rapid acetification method is an early example) 845 
and the submerged process were developed to reduce the acetification time while maintaining 846 
or increasing the quality. The rationale of the trickling generator processes is to increase the 847 
surface area for oxygen contact with the fermenting vinegar. Thereby, alcoholic substrates are 848 
circulated and trickled through vessels or vats containing an inert, non-compacting material, 849 
such as wood shavings or charcoal, on which a film of bacteria (AAB) is present. As the 850 
alcoholic substrate trickles downward through the material, contact with AAB and oxygen 851 
results in efficient oxidation to acetic acid. Once the substrate reaches the bottom it is re-852 
circulated over the bed to promote increased transformation to acetic acid (Hutkins, 2006). 853 
Therefore, the acidity successively increases. The trickling generator system has undergone a 854 
number of developments over the years. The Schutzenbach system, originating in 1823, 855 
developed the use of the solid packing material as a support for the bacteria and on which the 856 
vinegar was spread. Ham, in 1924, further developed this system, including forced aeration 857 
through the bed (counter-current to the downward flow of substrate) and the pumping and re-858 
distribution of the substrate over the bed by means of a sparger (Adams, 1998; Bourgeois & 859 
Barja, 2009). The Frings generator used wooden chips as the inert packing material. Today, 860 
while surface fermentations are still used for the production of low volume, high quality 861 
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vinegars such as the Orléans method for the production of Aceto Balsamico di Modena, most 862 
of the world’s vinegar is produced at large volume in submerged fermentations, described 863 
below (Emde, 2014).   864 
Submerged culture systems provide a much faster alternative and involve the suspension of 865 
AAB in the acetifying medium and application of stringent aeration to meet the high oxygen 866 
demand. The oxidative process occurs at the liquid-air interface of the bubbles, where the AAB 867 
convert ethanol into acetic acid, with limited production of other metabolites. The most 868 
successful, commonly applied submerged culture system is the Acetator®, built and sold by 869 
Heinrich Frings GmbH & Co. (Bonn, Germany). A significant design feature is its self-priming 870 
aerator, which provides for highly efficient dispersion of air in the liquid substrate (Adams, 871 
1998). 872 
This submerged method is more straightforward than the traditional method, consisting of 873 
application of the raw material and inoculum to the fermenter, the actual fermentation step, and 874 
final unloading of the bioprocessed product (Figure 4). A portion of the product is left in the 875 
vessel to act as starter culture for the next cycle (Tesfaye, Morales, García-Parrilla, & 876 
Troncoso, 2002). This method was introduced for the production of vinegar at the beginning 877 
of 20th century and is today employed for the production of most commercial vinegars of high 878 
consumption (Tesfaye et al., 2002). A disadvantage of this rapid method is that the high airflow 879 
leads to significant stripping of the volatile components from the original substrate, producing 880 
a more organoleptically limited product. Despite this, the rapidity of the process (vinegar can 881 
be produced in 24-hour cycles) and the high acidity achievable (acetic acid levels of up to 23–882 
25%, compared to 6–13% with traditional systems) are key advantages. Higher acidity makes 883 
transportation more cost-effective by reducing water transport.  884 
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Role of AAB in other fermented beverages 885 
Kombucha tea 886 
Kombucha tea is traditionally prepared with water, tea, sugar and a kombucha culture (“tea 887 
fungus”) in open vessels at room temperature for 1–3 weeks. This non-alcoholic, fermented 888 
beverage has a sharp acidity and specific flavour (De Roos & De Vuyst, 2018a). It is consumed 889 
traditionally in Eastern Europe and Asia. It is noteworthy that in Japan, the term “konbu-cha” 890 
can also refer to an unfermented beverage prepared with brown algae (Laminaria kelp). 891 
Consumption of kombucha was first recorded in 220 BC in Manchuria. More than one thousand 892 
years ago “tea fungus” was already consumed in Japan, China and India; then in Russia, Poland 893 
and the Baltic States starting in about 1915; in the Balkans, Germany and Eastern Europe 894 
around 1925; and in Spain, Italy, France and Switzerland in about 1955 (Kraft, 1959). Similar 895 
to other traditional beverages, the popularity of kombucha increased due to its purported 896 
beneficial health effects and its ease of preparation. To prepare a basic kombucha ferment, tea 897 
leaves are steeped in boiling water, 5 - 15% w/v of sucrose is added, and the mixture is brought 898 
to room temperature. A “mother” kombucha pellicle, produced from a previous kombucha 899 
fermentation, is placed into the tea along with liquid from a previous ferment (10 - 20% v/v). 900 
This pellicle is sometimes referred to as a symbiotic culture of bacteria and yeasts (SCOBY), 901 
and is comprised of primarily AAB and ethanol-forming yeasts in a thick cellulose pellicle 902 
(Figure 5). The pellicle floats on the liquid surface, at the air interface and grows vertically, 903 
increasing biomass with cellulose striations as the fermentation matures. After 1 - 3 weeks 904 
incubation at 20 - 30°C, the tea becomes a sweet and sour, naturally carbonated beverage due 905 
to microbial activity (Chen & Liu, 2000; Jayabalan, Malbaša, Lončar, Vitas, & Sathishkumar, 906 
2014; Malbaša et al., 2006). 907 
 908 
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The primary metabolites in a kombucha fermentation are sugars and organic acids. Yeasts 909 
convert sucrose to glucose and fructose, and produce ethanol, preferentially from the fructose 910 
(Blanc, 1996, Dufresne & Farnworth, 2000). Acetic acid bacteria then convert this ethanol into 911 
acetic acid (which gives kombucha its sour flavour) and glucose to GA. The pH of the medium 912 
decreases to around 2.6, signifying the maturation of the beverage, ready for consumption 913 
(Malbaša et al., 2006). If fermentation is not halted or slowed, the concentrations of acetic acid 914 
and GA can increase to levels of greater than 4 g/100 mL, but the beverage is then unsuitable 915 
for consumption due to a strong vinegar flavour (Chen & Liu, 2000).  916 
The microbial composition of kombucha varies depending on the source of the inoculum. The 917 
basic requirements for a kombucha ferment are at least one cellulose-producing AAB, and at 918 
least one yeast that can split sucrose into glucose and fructose. Multiple microorganisms can 919 
be present in a kombucha ferment, performing these essential roles along with producing 920 
additional secondary metabolites that contribute to the final beverage (Jarrell, Cal, & Bennett, 921 
2000; Mayser, Fromme, Leitzmann, & Gründer, 1995; Roussin, 1996). The most frequently 922 
isolated genera of bacteria from kombucha are Acetobacter, Komagataeibacter, 923 
Gluconacetobacter and Lactobacillus (Chen & Liu, 2000; Trovatti, Serafim, Freire, Silvestre, 924 
& Neto, 2011). The predominant AAB found in kombucha ferments are K. xylinus, A. 925 
pasteurianus, A. aceti, and G. oxydans (Liu, Hsu, Lee, & Liao, 1996; Marsh, O'Sullivan, Hill, 926 
Ross, & Cotter, 2014). K. xylinus – previously known as Ga. xylinus (Yamada et al., 2012), 927 
and A xylinum (Yamada, Hoshino, & Ishikawa, 1997) – are the most abundant (80 - 99%) 928 
prokaryotes in kombucha (Chen & Liu, 2000; Marsh et al., 2014) and are responsible for the 929 
formation of the cellulosic pellicle (Chen & Liu, 2000; Zhu, Li, Zhou, Lin, & Zhang, 2014). 930 
Other AAB species have potential for both cellulose production and nitrogen fixation 931 
(Cleenwerck, De Wachter, González, De Vuyst, & De Vos, 2009; Dutta & Gachhui, 2007; Tan, 932 
Ren, Cao, Chen, & Tang, 2012).  933 
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 934 
Water kefir 935 
Water kefir is a fermented, low-alcohol beverage with acidic and fruity flavours (De Roos & 936 
De Vuyst, 2018a). It is produced via spontaneous fermentation of a water solution containing 937 
approximately 8% (w/v) sucrose, (dried) fruits (e.g., figs), and water kefir grains (these 938 
“grains” are essentially a polysaccharide mass encapsulating a complex microbial association 939 
of bacteria and yeasts which serve as a starter culture) in a closed container at room temperature 940 
for 2–4 days (Figure 6) (Fiorda et al., 2017; Laureys & De Vuyst, 2014). Currently the main 941 
market for this beverage is in the USA, Japan, France, and Brazil, where it is consumed for its 942 
reported functional properties (Fiorda et al., 2017). The water kefir grain inoculum, and the 943 
nature of the substrate (such as the type of fruit used) determines the grain growth, the microbial 944 
species diversity, the metabolites formed and their concentrations (Laureys, Aerts, Vandamme, 945 
& De Vuyst, 2018; Laureys & De Vuyst, 2017; Laureys, Van Jean, Dumont, & De Vuyst, 946 
2017). In general, the microbiota of water kefir is known to be a stable consortium of different 947 
LAB (such as Lactobacillus, Leuconostoc), AAB (Acetobacter, Gluconacetobacter, and 948 
Gluconobacter) and yeasts (Kluyveromyces, Brettanomyces, Pichia, and Saccharomyces). A 949 
strong symbiosis between these three microbial groups is documented (Fiorda et al., 2017). 950 
Yeast metabolism promotes the growth of acidophilic bacterial species such as LAB and AAB. 951 
Glucose and fructose are made available for LAB growth through the action of yeast invertase 952 
on sucrose. Ethanol produced by yeasts may be metabolised to acetic acid by any viable AAB 953 
present (Magalhaes, Pereira, Dias, & Schwan, 2010). Growth of AAB particularly takes place 954 
under aerobic conditions, leading to increased acetic acid content, which may be unwanted 955 
(Gulitz, Stadie, Ehrmann, Ludwig, & Vogel, 2013; Laureys et al., 2017; Marsh, O'Sullivan, 956 
Hill, Ross, & Cotter, 2013). Under anaerobic conditions they remain in a viable but non-957 
culturable (VBNC) state, being metabolically dormant, but can start to grow when oxygen 958 
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becomes accessible (Laureys et al., 2017). While several species from the genera Acetobacter, 959 
Gluconacetobacter, and Gluconobacter have been recovered from water kefir fermentation 960 
processes, Acetobacter species seem to be best adapted to this ecosystem (Laureys & De Vuyst, 961 
2014; Laureys et al., 2017; Magalhaes et al., 2010; Marsh et al., 2013). 962 
 963 
Lambic beer 964 
Lambic sour beers are among the oldest types of refreshing, alcoholic, acidic beers still brewed 965 
and which have become increasingly popular worldwide (De Roos & De Vuyst, 2018a, 2018b; 966 
Pothakos et al., 2016). In particular, sour beers are now attracting interest in the USA. In the 967 
American craft-brewing sector, American coolship ales, for instance, mimic the lambic beer 968 
production method (Bokulich, Bamforth, & Mills, 2012). Such beers were once a seasonal 969 
product from craft breweries, but today some produce solely sour beers, much like traditional 970 
Belgian lambic breweries. 971 
Lambic beer is the result of a spontaneous fermentation process of a barley and unmalted wheat 972 
extract (wort) that continues for 1 - 3 years (De Keersmaecker, 1996). The fermentation process 973 
is not driven by yeasts or bacteria applied as starter cultures, but by a spontaneous inoculum 974 
from the environment. Microbial growth begins during the cooling of the boiled wort which 975 
occurs overnight in a shallow open vessel, known as a cooling tun or coolship. These beers are 976 
traditionally brewed close to the Senne river valley, near Brussels, Belgium (Spitaels et al., 977 
2014a). The following morning the cooled wort is assumed to have been inoculated with the 978 
specific air microbiota of this region and is transferred into wooden casks which are stored at 979 
cellar or ambient temperatures, i.e., typically between 15 and 25°C. The wort then ferments 980 
and matures in these casks. In addition to inoculation from the environment during the coolship 981 
step, microorganisms present on the interior surfaces of the casks also contribute to the 982 
fermenting wort, helping to establish a stable microbial community (De Roos, Van der Veken, 983 
& De Vuyst, 2018).  The end product is a non-carbonated sour beer that mainly serves as a 984 
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base for gueuze or fruit lambic beers. Several studies have shown a microbial succession of 985 
Enterobacteriaceae and wild (oxidative) yeasts, including a yeast fermentation phase with 986 
Saccharomyces cerevisiae and/or Saccharomyces pastorianus, an acidification phase with 987 
Pediococcus damnosus and/or Lactobacillus brevis, and a maturation phase with Dekkera 988 
(Brettanomyces) bruxellensis (De Roos & De Vuyst, 2018b). AAB are only occasionally 989 
isolated during the lambic beer fermentation and maturation process, probably due to their 990 
VBNC state (Spitaels et al., 2014a; Spitaels et al., 2015). However, two new AAB species have 991 
been described that seem to be characteristic for lambic beers, namely Acetobacter lambici 992 
(Spitaels et al., 2014b) and Gluconobacter cerevisiae (Spitaels et al., 2014c). It is possible that 993 
the AAB, being obligate aerobes, are concentrated at the wort/air interface and, hence, are 994 
missed during submerged sampling of the casks. Indeed, this has recently been proven to be 995 
the case by De Roos et al. (2018a), who showed that the liquid nearest the interface was 996 
characterized by higher AAB counts and higher concentrations of their metabolites (De Roos 997 
et al., 2018a).   998 
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Biotechnological applications of Gluconobacter oxydans relevant to the food industry 999 
Apart from their historical and key role in the production of fermented foods such as vinegar, 1000 
AAB are also important for the production of useful compounds that find application in the 1001 
food industry. The formation of GA by Gluconobacter oxydans, and their role in the process 1002 
of Vitamin C synthesis are discussed here. 1003 
 1004 
Gluconic acid production and regulation 1005 
The applications of GA in the food industry include use as an acidity regulator (E574–E580), 1006 
with raising, sequestering and flavour-enhancing properties. Gluconic acid enhances the 1007 
sensory characteristics of foods by imparting a bitter but refreshing taste.  Gluconic acid and 1008 
its derivative glucono-δ-lactone are also used as food preservatives. Its ketogluconate, 5-KGA, 1009 
also has important uses, including as a precursor in the production of tartaric acid, xylaric acid, 1010 
as well as for Vitamin C production (Cañete-Rodríguez et al., 2016). Two methods are 1011 
commonly employed for the biotechnological production of GA, use of the fungus Aspergillus 1012 
niger, or use of an AAB strain, primarily G. oxydans. The biochemistry of the production of 1013 
GA and associated ketogluconates has been described above. This section will examine the 1014 
factors influencing GA production in G. oxydans.  This subject was reviewed recently by 1015 
García-García et al. (2017) and will be discussed briefly below (García-García et al., 2017). 1016 
The main factors which affect the production of GA include, in decreasing order of importance, 1017 
pH, initial concentration of glucose in the medium, concentration of calcium carbonate added 1018 
to the medium and the dissolved oxygen level. 1019 
Using G. oxydans 621H it was found that below pH 3.5 - 4 uptake and assimilation of GA into 1020 
the PPP is almost completely inhibited (Olijve & Kok, 1979). This is likely to be related to the 1021 
pH optima for the various enzymes involved in these processes – the periplasmic 1022 
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dehydrogenases involved in oxidative fermentation have pH optima in the acidic range of pH 1023 
3 – 6, while those cytoplasmic (NAD(P)-dependent) dehydrogenases have optima in the 1024 
alkaline range of pH 8 – 11 (García-García et al., 2017). Therefore, the production of GA and 1025 
associated pH drop may promote its own production and accumulation as the periplasmic 1026 
dehydrogenases become more active. As outlined above, GA can be further oxidised to 1027 
ketogluconates such as 2KGA and 5KGA, thus reducing the GA yield. Olijve and Kok (1979) 1028 
and Weenk et al. (1984) found glucose to be rapidly oxidized virtually quantitatively to GA 1029 
without formation of any ketogluconates if the pH of the fermentation was uncontrolled (which 1030 
lead to a rapid pH drop), or if the pH was adjusted to 2.5 at the beginning of the fermentation 1031 
(Olijve & Kok, 1979; Weenk, Olijve, & Harder, 1984). However, control of the pH at 5.5, or 1032 
the addition of calcium carbonate to the medium, lead to 2KGA and 5KGA formation once all 1033 
initial glucose had been utilised (Weenk et al., 1984). The presence of calcium carbonate in the 1034 
medium promotes ketogluconate production (Beschkov, Velizarov, & Peeva, 1995). It has been 1035 
postulated that, in the absence of pH control, the formation of ketogluconates may be 1036 
completely inhibited (Beschkov et al., 1995; Velizarov & Beschkov, 1994).  1037 
The initial glucose concentration also strongly influences the production of GA and 1038 
ketogluconates. Olijve and Kok (1979) found that high glucose concentrations (0.9 – 2.7 g/L) 1039 
led to rapid GA accumulation, while at lower concentrations the assimilation of glucose and 1040 
metabolism in the PPP was favoured (Olijve & Kok, 1979). This is understandable from an 1041 
ecological viewpoint when considering the level of glucose in the environment. If the 1042 
concentration is low, AAB will preferentially assimilate the glucose for biomass production; 1043 
in contrast, in the case of high glucose concentrations, the majority of it will be oxidised to 1044 
gluconate and ketogluconates, thus making it unavailable for competing microorganisms, while 1045 
also lowering the pH of the environment (García-García et al., 2017). Because GA is produced 1046 
from the oxidation of glucose and the amount which is formed is directly proportional to the 1047 
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initial glucose concentration, it is logical that above a certain concentration of glucose, the 1048 
amount of GA formed will become inhibitory due to the resultant low pH, thus preventing 1049 
further production. Thus, a glucose concentration above 90 g/L led to a reduced rate and yield 1050 
of GA compared to a lower glucose concentration. Long lag phases were observed due to the 1051 
combined effect of high glucose concentration and the low pH due to GA formation (Velizarov 1052 
& Beschkov, 1994, 1998). High glucose concentrations (~90 g/L) also favoured GA production 1053 
over ketogluconate formation (Beschkov et al., 1995; García-García et al., 2017). 1054 
Compared to the effects of pH and glucose concentration, dissolved oxygen (DO) has a less 1055 
important role on the production of GA. However, Buse et al. (1992) found that DO control 1056 
had a significant impact on the formation of 2,5-diKGA in G. oxydans ATCC 9937 (formerly 1057 
Gluconobacter oxydans subsp. melanogenum). This was related to changes in the activity of 1058 
the enzyme gluconate dehydrogenase (the first enzyme in the conversion of GA to 1059 
ketogluconates) at different oxygenation levels. Low oxygen (<30%) delayed the production 1060 
of this enzyme (Buse, Qazi, & Onken, 1992). Thus, low DO levels appear to inhibit GA 1061 
conversion to ketogluconates and it is conceivable that relatively low DO levels may have a 1062 
similar effect in G. oxydans.  1063 
 1064 
Vitamin C production and potential for direct formation by G. oxydans  1065 
Since 1934 and until the late 1990s, the “Reichstein process” has been used as the main process 1066 
for the production of Vitamin C, also known as L-ascorbic acid (Asc), of which more than 1067 
110,000 tones are produced annually (Bremus, Herrmann, Bringer-Meyer, & Sahm, 2006). 1068 
This process, although refined and improved over the years, contains a number of chemical 1069 
steps, and only a single microbially-catalysed step, and is highly energy intensive. Therefore, 1070 
it has been replaced, particularly in China, by the so-called (Classical) Two-Step Fermentation 1071 
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Process which is less costly and more environmentally friendly (Yang & Xu, 2016). Figure 7 1072 
shows the various routes for Asc production; while different processes have been studied, the 1073 
Two-Step Fermentation process is today the primary method used for industrial Asc production 1074 
(Wang et al., 2018), with China supplying 80% of the global demand. Royal DSM remains the 1075 
sole Western Vitamin C producer (Pappenberger & Hohmann, 2014). Each of the routes to 1076 
Asc, particularly with reference to the microorganism involved and especially G. oxydans, will 1077 
be discussed further below.  1078 
D-glucose, D-sorbitol or D-sorbose can be considered as common starting materials for the 1079 
process; however, glucose must be chemically converted to sorbitol which is typically via 1080 
hydrogenation (Yang & Xu, 2016). Central in each process is the production of the precursor, 1081 
2-keto-L-gulonic acid (2-KLGA). For a detailed treatment of this topic, readers are also 1082 
referred to the recent review by Wang et al. (2018) (Wang et al., 2018). 1083 
The Reichstein process: This process consists mainly of chemical reactions for Asc synthesis, 1084 
with only one microbially-catalysed step. This is the oxidation of D-sorbitol to L-sorbose and 1085 
which is performed by AAB due to their very efficient oxidation of carbohydrates and sugar 1086 
alcohols. Originally this bioconversion was performed by Acetobacter aceti subsp. xylinum 1087 
(now Komagataeibacter xylinus); subsequently Gluconobacter suboxydans (now G. oxydans) 1088 
was introduced due to its greater capacity for oxidation and has been employed to date, with 1089 
an almost 100% conversion rate on an industrial scale (Pappenberger & Hohmann, 2014; Yang 1090 
& Xu, 2016). This is a key reaction, common to each route to Asc production, as can be seen 1091 
in Figure 7. The key enzyme mediating the conversion of D-sorbitol to L-sorbose is glycerol 1092 
dehydrogenase (GLDH), a PQQ-dependent membrane protein. This enzyme is also known as 1093 
D-sorbitol dehydrogenase (SLDH), but it is a major polyol dehydrogenase in G. oxydans with 1094 
broad substrate specificity for other sugar alcohols besides sorbitol, such as D-mannitol, D-1095 
arabitol, meso-erythritol, D-adonitol and glycerol (Figure 1) (Matsushita et al., 2003; Sugisawa 1096 
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& Hoshino, 2002). A second membrane-bound sorbitol oxidising enzyme, which is specific for 1097 
sorbitol, has been found in G. oxydans and other Gluconobacter species but is FAD-dependent 1098 
i.e. FAD-SLDH (Shinjoh & Toyama, 2016). Genome analysis of the industrial strain G. 1099 
oxydans H24 identified three sorbitol oxidising enzymes, two membrane bound and one 1100 
cytoplasmic, namely PQQ-SLDH (PQQ-GLDH), FAD-SLDH and NADP-SLDH, respectively 1101 
(Ge et al., 2013). Among these, PQQ-GLDH is believed to play the primary role in converting 1102 
D-sorbitol to L-sorbose (Matsushita et al., 2003). 1103 
Two-Step Fermentation process: This process can be considered as an improvement on the 1104 
Reichstein process. Two fermentations are performed in this process; the first, the 1105 
bioconversion of D-sorbitol to L-sorbose is the same as that of the Reichstein process and is 1106 
performed by G. oxydans. The second fermentation involves the conversion of sorbose to the 1107 
Asc precursor, 2-KLGA. The subsequent transformation of 2-KLGA into Asc is performed 1108 
through a number of chemical steps, as for the Reichstein process. Therefore, it is the second 1109 
fermentation that differentiates the Two-Step Fermentation process from the Reichstein 1110 
process (Yang & Xu, 2016). This fermentation is performed by a two-strain co-culture system, 1111 
neither of which is actually an AAB. This dual culture consists of the 2-KLGA-producing strain 1112 
and a “helper” or companion strain which promotes the growth of the 2-KLGA producer. Early 1113 
studies identified the 2-KLGA producer as G. oxydans, but it was later renamed 1114 
Ketogulonicigenium vulgare, a Gram-negative, facultatively anaerobic, chemoheterotrophic 1115 
soil microorganism (Urbance, Bratina, Stoddard, & Schmidt, 2001). The companion strain, 1116 
typically a species of Bacillus, is considered to stimulate K. vulgare growth and 2-KLGA 1117 
accumulation by releasing particular metabolites (Feng, Zhang, & Zhang, 2000). B. 1118 
megaterium and B. cereus were the primary companion strains applied in industrial Asc 1119 
fermentation, and while many spore-forming strains have been found to be suitable as 1120 
companion strains, only K. vulgare has been used in industrial fermentation so far (Feng et al., 1121 
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2000; Jiao, Zhang, Xie, Yuan, & Chen, 2002; Urbance et al., 2001). Two enzymes in K. vulgare 1122 
are key in the oxidation of L-sorbose to 2-KLGA. These are L-sorbose/L-sorbosone 1123 
dehydrogenase (SSDH) and L-sorbosone dehydrogenase (SNDH). SSDH is a unique PQQ-1124 
dependent membrane dehydrogenase, with dual catalytic ability, catalysing not only the 1125 
conversion of L-sorbose to L-sorbosone but also that of L-sorbosone to 2-KLGA (Asakura & 1126 
Hoshino, 1999). In addition, the SNDH of K. vulgare has been found to catalyse the direct 1127 
conversion of L-sorbosone to Asc (Miyazaki, Sugisawa, & Hoshino, 2006). Thus, via the action 1128 
of SSDH and SNDH it is possible for K. vulgare to directly produce Asc from L-sorbose and/or 1129 
L-sorbosone (Sugisawa, Miyazaki, & Hoshino, 2005).  Genome sequencing of the industrial 1130 
strain, K. vulgare Y25, found that it contained four genes encoding SSDH and one plasmid-1131 
encoded gene for SNDH (Liu et al., 2011). The absence of genes or operons for the biosynthesis 1132 
of many amino acids, nucleotides and cofactors may explain its dependence on a companion 1133 
strain. As stated, the primary microorganism in the Two-Step Fermentation process is not an 1134 
AAB sensu stricto; however, homologous enzymes to those employed by K. vulgare have been 1135 
found in G. oxydans (Shinjoh & Toyama, 2016), and the potential of this bacterium for the 1136 
direct production of 2-KLGA and Asc is described next. 1137 
Microbial production of 2-KLGA and Asc by G. oxydans: There has been interest in the further 1138 
exploitation of G. oxydans in Asc production, beyond its use for sorbitol oxidation. This has 1139 
been supported by the observation in recent decades of enzymes in certain strains of G. oxydans 1140 
which perform similar bioconversions to those in K. vulgare, strengthening the possibility of, 1141 
in the future, using a single microorganism for direct 2-KLGA or Asc production. Thus, strains 1142 
of G. oxydans have been demonstrated to produce 2-KLGA from both D-sorbitol and L-1143 
sorbose, albeit at very low yields with wild-type strains. For example, G. oxydans NBRC3292 1144 
(formerly G. oxydans IFO3292 and G. melanogenus ATCC15163) was shown to produce 1145 
6.5g/L 2-KLGA from 50 g/L sorbitol over a 150 h fermentation time (Motizuki et al., 1962). 1146 
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A similar strain, G. oxydans NBRC3293 (formerly G. oxydans IFO3293 and G. melanogenus 1147 
IFO3293) produced 2.8 g/L 2-KLGA from 25 g/L L-sorbose over 168 h fermentation 1148 
(Sugisawa et al., 1990). A progenitor strain of IFO3293, designated SPO1, was isolated and 1149 
produced 13g/L of 2-KLGA from 50 g/L L-sorbose. Subsequent strain improvement studies 1150 
with strain SPO1 using mutagens such as UV irradiation resulted in the isolation of genetically 1151 
modified strains producing 50 to 60 g/L 2-KLGA from 100g/L D-sorbitol or 100 g/L L-sorbose 1152 
over 80 to 100 h. Particular mutant isolates arising from the above strain improvement studies, 1153 
which have been subsequently extensively studied regarding Asc production by G. oxydans, 1154 
are strains UV10 and N44-1 (Pappenberger & Hohmann, 2014). L-sorbose dehydrogenase 1155 
(SDH) was identified in the mutant strain UV10. The enzyme was membrane bound and FAD-1156 
dependent with a high activity for L-sorbose (L-sorbosone as product). In addition, L-1157 
sorbosone itself was also identified as a substrate for SDH, with 2-KLGA as the product. Thus, 1158 
this SDH in G. oxydans UV10 has very similar activity to the SSDH of K. vulgare described 1159 
above. Similarly, a SNDH was identified in G. oxydans UV10, this enzyme being found in the 1160 
cytosolic fraction and being NAD(P)-dependent, with 2-KLGA as the product (Hoshino, 1161 
Sugisawa, & Fujiwara, 1991; Pappenberger & Hohmann, 2014). A second strain of G. oxydans, 1162 
T-100, was subsequently shown to contain the same dehydrogenases (Saito et al., 1997). Based 1163 
on genome analysis, homologs of the associated genes are present in many Gluconobacter sp. 1164 
(Gao, Zhou, Liu, Du, & Chen, 2012; Wang et al., 2018). Thus, the formation of 2-KLGA in G. 1165 
oxydans is mediated by either of two enzymes: the membrane bound SDH i.e. from L-sorbose 1166 
or L-sorbosone, or, the cytosolic SNDH, from L-sorbosone. The more recent observation of 1167 
small amounts of Asc production by G. oxydans NBRC3293 when provided with L-sorbosone 1168 
has led to the identification of a second type of L-sorbosone dehydrogenase in G. oxydans. In 1169 
contrast to the FAD-dependent cytosolic SNDH of G. oxydans UV10, this enzyme was 1170 
membrane bound and PQQ-dependent and was designated SNDHai (Berry, Lee, Mayer, & 1171 
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Shinjoh, 2003). A homologous enzyme, designated SNDHak was identified in K. vulgare 1172 
(Miyazaki et al., 2006). Although SNDHai uses L-sorbosone as a substrate, which it converts 1173 
directly to Asc, it displays much higher activity for the cyclic polyol, myo-inositol; thus, it has 1174 
been suggested that L-sorbosone oxidation by SNDHai may be a case of fortuitous cross-1175 
reactivity with the non-physiological L-sorbosone (Pappenberger & Hohmann, 2014). As 1176 
shown in Figure 7(d), as little as three periplasmic oxidation steps are required to convert 1177 
sorbitol to Vitamin C – mediated by GLDH, SDH and SNDHai – all of which are endogenous 1178 
G. oxydans enzymes (Pappenberger & Hohmann, 2016). Despite low yields of Asc, the 1179 
identification of SNDHai has, nevertheless, increased the possibility that G. oxydans may, at 1180 
some future point, be used as the sole microorganism for the direct production of Vitamin C. 1181 
With respect to the yield of Asc, there are three challenges which need to be overcome. Firstly, 1182 
the low affinity of SNDHai for L-sorbosone, as described above. Secondly, the presence of the 1183 
cytoplasmic SNDH in G. oxydans means that a certain proportion of the L-sorbosone will be 1184 
converted to 2-KLGA and therefore not to Asc. Thirdly, and most critically, is the stability of 1185 
Asc once it is produced. This is primarily due to the reductive properties of Asc and its 1186 
propensity to become oxidised, forming L-dehydroascorbic acid. If L-dehydroascorbic acid is 1187 
not rapidly reduced to again form Asc, it spontaneously and irreversibly degrades with a half-1188 
life of minutes. In this way, Asc is oxidised by molecular oxygen, and this reaction is 1189 
accelerated at above neutral pH and in the presence of trace amounts of transition metal ions. 1190 
The challenge is that such trace metals are required as a growth factor and, moreover, the 1191 
strictly oxidative metabolism of AAB means that the presence of molecular oxygen is clearly 1192 
unavoidable (Pappenberger & Hohmann, 2016). Attempts to overcome such barriers have 1193 
included the use of resting cells in media in the absence of detrimental substances or with the 1194 
use of engineered strains. Using the latter approach, a near 90% substrate conversion and yields 1195 
of 10 g/L Asc were achieved using a genetically engineered strain of G. oxydans that was over-1196 
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expressing genes for SDH and SNDHai and also had a gene knockout for cytoplasmic SNDH 1197 
(Pappenberger & Hohmann, 2016). Thus, it appears that at the current state of the science and 1198 
knowledge, significant yields of Asc using (wild-type) G. oxydans alone are not yet possible 1199 
without the use of engineered strains. 1200 
It is noteworthy that G. oxydans has also the potential to be used for the biosynthesis of 2-1201 
KLGA via a different mechanism to the D-sorbitol pathway, that is, via the biosynthesis of GA 1202 
and its associated ketogluconates - the 2,5-diKGA pathway (Figure 7(e)). In this system the 1203 
bioconversion of glucose as substrate into 2-KLGA is performed by cell preparations 1204 
containing the necessary complement of enzymes such as glucose dehydrogenase, D-gluconate 1205 
and 2-keto-D-gluconate dehydrogenase, including cytochrome C as a co-factor. A final 1206 
enzyme, 2,5-diKGA reductase, performs the conversion of 2,5-diKGA into 2-KLGA (Hancock 1207 
& Viola, 2002). As has been discussed above, specific G. oxydans strains have the potential to 1208 
produce 2,5-diKGA from glucose oxidation via GA. Indeed, resting cells of G. oxydans have 1209 
been used as a source of gluconate dehydrogenase and 2-keto-D-gluconate dehydrogenase for 1210 
2-KLGA formation via the 2,5-diKGA pathway (Hancock & Viola, 2002; Ji & Gao, 2001). 1211 
However, most research into this pathway have used species of Erwinia and Corynebacterium 1212 
as the enzyme sources (Wang et al., 2018). 1213 
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Beneficial effects of AAB-fermented products 1214 
Health benefits associated with vinegar consumption 1215 
Vinegar is today primarily used as a condiment or seasoning alone, or as a seasoning and 1216 
preservative agent in salad dressings, mayonnaise, ketchup and similar condiment sauces for 1217 
its desirable organoleptic properties. However, in historical times it was used medicinally, as 1218 
described above (Budak et al., 2014). A number of beneficial effects on health have been 1219 
claimed to be associated with the consumption of vinegar, and while these are numerous, only 1220 
few are based on clear evidence (Mas, Troncoso, García-Parrilla, & Torija, 2016). Health 1221 
benefits associated with vinegar include antimicrobial activity, antioxidant activity, modulation 1222 
of the glycaemic response, positive effects on cardiovascular health, such as cholesterol-1223 
lowering and antihypertensive action, positive effects in weight loss, improvement of appetite, 1224 
reduction of fatigue and anticancer activity (Chen et al., 2016). Organic acids, primarily acetic 1225 
acid, and polyphenols have been attributed as the main functional compounds in vinegar and 1226 
are present in all varieties at varying levels (Chen et al., 2016). Other bioactive compounds, 1227 
their presence and concentration which can vary depending on the type of vinegar and substrate 1228 
material, may also contribute to the functionality e.g. tryptophol as an anticancer compound in 1229 
Japanese black soybean vinegar (Inagaki et al., 2007). Certain factors influence the chemical 1230 
composition of vinegar and thus its functional properties, including the raw material, the 1231 
production process (acetification method) and the amount of time spent aging in wood 1232 
(Guerreiro, de Oliveira, Ferreira, & Catharino, 2014). 1233 
The antibacterial effects of vinegar have mainly been investigated in the context of in-vitro 1234 
application to food products, such as fresh fruits and vegetables, for the inhibition of pathogenic 1235 
bacteria. The antibacterial mechanism of vinegar is primarily due to its acetic acid content. 1236 
When the bactericidal effects of a number of organic acids, including lactic acid, acetic acid, 1237 
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citric acid, and malic acid on Escherichia coli O157:H7 were investigated, acetic acid was 1238 
found to be most effective, followed by lactic acid, citric acid, and malic acid. Other pathogens 1239 
inhibited by acetic acid included Salmonella enterica subsp. enterica, Vibrio 1240 
parahaemolyticus, Staphylococcus aureus, Aeromonas hydrophila, and Bacillus cereus 1241 
(Entani, Asai, Tsujihata, Tsukamoto, & Ohta, 1998). Chang and Fang (2007) observed a 3-log 1242 
reduction in numbers of E. coli O157:H7 when rice vinegar containing 5% acetic acid was 1243 
applied to lettuce for 5 min at 25°C. Use of lower acetic acid levels led to less of a reduction 1244 
within the same time (Chang & Fang, 2007). The antimicrobial activity of organic acids is 1245 
influenced by the target bacterial strain(s), temperature, pH, acid concentration, and ionic 1246 
strength (Budak et al., 2014). The properties of undissociated organic acids such as fat-1247 
solubility and neutral charge enable them to diffuse through the cell membrane of the target 1248 
microorganism and enter the cell; in the cytoplasm, the higher intracellular pH causes the acid 1249 
to become dissociated, producing hydrogen ions. Hydrogen ion production thus reduces the 1250 
intracellular pH and interferes with cellular processes, such as enzyme activity, DNA 1251 
replication and transcription, and protein expression, therefore effecting the normal growth of 1252 
the microorganism (Chen et al., 2016). Acetic acid is a particularly effective antimicrobial 1253 
because at a relatively high pH (pH 4.7 = pKa of acetic acid) it exists primarily in its 1254 
undissociated form and can enter the cell. Other organic acids, for example lactic acid, are not 1255 
as effective; lactic acid cannot easily enter cells at a pH>3.8 (its pKa) as it exists primarily in 1256 
its dissociated form.  1257 
A high oxidant and low antioxidant level in the human body is associated with the development 1258 
of chronic, inflammatory diseases, such as cancer and cardiovascular disease (Srdic-Rajic & 1259 
Konic Ristic, 2016). Intake of dietary antioxidants inhibit the formation of peroxides and their 1260 
absorption in the gastrointestinal tract (Verzelloni, Tagliazucchi, & Conte, 2007). Vinegar 1261 
exhibits antioxidant capacity which has been associated with the presence of polyphenols and 1262 
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derived phenolic compounds, such as, gallic acid, caffeic acid, p-coumaric acid and ferulic acid 1263 
amongst many others (Garcia-Parrilla, Torija, Mas, Cerezo, & Troncoso, 2017). In addition, 1264 
carotenoids, phytosterols and vitamins, such as Vitamins C and E, and melanoidins also 1265 
contribute to the antioxidant capacity (Ho et al., 2017; Tagliazucchi, Verzelloni, & Conte, 1266 
2010). As stated above, the processes used in vinegar production can influence its chemical 1267 
composition, and it is noteworthy that, in the case of the phenolic composition, contact with 1268 
wood can influence the phenolic content, due to polyphenol release via alcoholysis of wood 1269 
lignin (Tesfaye et al., 2002).   1270 
It has been demonstrated in-vitro that the antioxidant capacity of Traditional Balsamic Vinegar 1271 
(TBV) was equal to that of a 0.2% Vitamin C solution (Chen et al., 2016). Tagliazucchi et al. 1272 
(2008) showed, in-vitro, that TBV had antioxidant activity equal to or higher than that of red 1273 
wine, with 45% of the antioxidant activity due to the total polyphenolic fraction, primarily 1274 
tannins, and 45% due to melanoidins and other lower molecular mass Maillard reaction 1275 
products (Tagliazucchi, Verzelloni, & Conte, 2008). TBV melanoidins were responsible for 1276 
preventing the pro-oxidant and cytotoxic effects of heme during simulated gastric digestion of 1277 
meat (Verzelloni, Tagliazucchi, & Conte, 2010). Kurosu, a Japanese vinegar produced from 1278 
unpolished rice, has been reported to have a high antioxidant activity. An ethyl acetate extract 1279 
of kurosu inhibited myeloperoxidase activity, hydrogen peroxide generation and lipid 1280 
peroxidation in mouse skin cells, and had the highest antioxidant activity compared to ethyl 1281 
acetate extracts of grain vinegar, apple vinegar and wine vinegar (Nishidai et al., 2000).   1282 
Vinegar has been described to have an antiglycaemic effect and to improve blood glucose 1283 
control and insulin resistance. Indeed, before the advent of pharmacological hypoglycaemic 1284 
agents, vinegar “teas” were consumed by diabetics to help manage their condition (Johnston & 1285 
Gaas, 2006). Many types of vinegars including apple cider vinegar, ginsam vinegar (an Asian 1286 
vinegar produced from Panax ginseng), and tomato vinegar are capable of reducing 1287 
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postprandial blood glucose and alleviating insulin resistance as well as promoting insulin 1288 
production. This antiglycaemic effect of vinegar was first reported by Ebihara and Nakajima 1289 
(1988). The authors found that co-administration of 2% acetic acid with a high glycaemic load 1290 
meal consisting of 10% corn starch, significantly reduced the blood glucose response in rats 1291 
(Ebihara & Nakajima, 1988). In human subjects, the consumption of sucrose accompanied by 1292 
vinegar decreased the area under the insulin response curve by 20% (Johnston & Gaas, 2006). 1293 
Administration of 20 mL white vinegar (equivalent to 5% acetic acid) as a salad dressing with 1294 
a mixed meal consisting of white bread (50 g carbohydrate) and lettuce reduced the glycaemic 1295 
response by over 30% in healthy individuals. Neutralisation of the acetic acid with sodium 1296 
bicarbonate destroyed this antiglycaemic effect (Brighenti et al., 1995). The substitution of 1297 
pickled cucumber for fresh cucumber in a meal consisting of bread, butter and yogurt reduced 1298 
the glycaemic index (GI) by over 30% in healthy subjects (Östman, Liljeberg Elmståhl, & 1299 
Björck, 2001). Similar results were observed by Johnston et al. (2010), who demonstrated that 1300 
the postprandial glucose response was reduced by 23% in healthy individuals fed a meal of a 1301 
bagel and juice containing 10 g apple cider vinegar (5% acidity), but not by the same meal 1302 
containing neutralised vinegar. It was concluded that the neutralised salt of acetic acid (acetate) 1303 
does not appear to possess antiglycaemic properties. In addition, ingestion of vinegar five hours 1304 
before the meal reduced the antiglycaemic effect compared to consumption of vinegar with the 1305 
meal (Johnston, Steplewska, Long, Harris, & Ryals, 2010).  1306 
Vinegar has also been shown to modulate the glucose response and insulin sensitivity in 1307 
diabetic individuals. In patients with type 2 diabetes, dietary consumption of acetic acid 1308 
significantly reduced the level of glycated haemoglobin (0.16%) during a 12-week experiment 1309 
(Johnston, White, & Kent, 2009). Furthermore, in healthy individuals at risk of developing type 1310 
II diabetes mellitus, ingestion of 0.75 g acetic acid as a vinegar drink twice daily at mealtime, 1311 
for 12 weeks, reduced fasting blood glucose levels, and to a greater extent than diabetic 1312 
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pharmaceutical medications (Johnston, Quagliano, & White, 2013). This is in agreement with 1313 
an earlier study by Johnston et al. (2004) which showed that ingestion of a vinegar drink (20 g 1314 
vinegar, 40 g water, 1 tablespoon saccharine) by individuals with insulin resistance (pre-1315 
diabetic) had a marked reduction in postprandial glycaemia (64%) and improved insulin 1316 
sensitivity (34%) (Johnston, Kim, & Buller, 2004). 1317 
It has been reported that the reduction of postprandial glucose affected by vinegar in high GI 1318 
meals is not observed for low GI meals (Liatis et al., 2010). However, vinegar ingestion with 1319 
both high- and even low-GI meals does improve insulin sensitivity, independent of blood 1320 
glucose level, as glucose uptake was enhanced after both meal types when vinegar was also 1321 
ingested (Mitrou et al., 2015). Indeed, even the improvement by vinegar consumption of insulin 1322 
sensitivity alone is noteworthy, particularly in insulin-resistant (pre-diabetic) subjects, as trials 1323 
have demonstrated that slowing the progression to diabetes in high-risk individuals and 1324 
improving their insulin sensitivity may increase the probability that such individuals may revert 1325 
to a normal, glucose-tolerant state over time (Johnston & Gaas, 2006). 1326 
Postprandial blood glucose levels are primarily determined by 1) the rate that glucose enters 1327 
the blood and 2) the rate at which it is consumed in-vivo. The rate of gastric emptying, 1328 
digestion, and absorption in the small intestine determine the rate that glucose enters the blood 1329 
(Chen et al., 2016). It is not yet fully understood how vinegar modulates glucose metabolism. 1330 
Acetic acid in vinegar may supress carbohydrate absorption in the gut, more specifically 1331 
through reducing disaccharidase activity and decreasing the digestion of disaccharides and 1332 
oligosaccharides. Thus, monosaccharide absorption in the gut is reduced, lowering the blood 1333 
glucose level (Johnston et al., 2013). Ogawa et al. (2000) demonstrated that acetic acid 1334 
significantly inhibited the disaccharidase (e.g. sucrase, lactase) activity of Caco-2 cells, an 1335 
effect not seen with other organic acids such as lactic acid or citric acid (Ogawa et al., 2000). 1336 
In addition, acetic acid may regulate glucose metabolism by promoting uptake of glucose by 1337 
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the liver and skeletal muscle and its conversion to glycogen stores (Hlebowicz, Darwiche, 1338 
Bjorgell, & Almer, 2007). In this case, the mechanism by which glucose metabolism is 1339 
regulated is believed to be through activation of the adenosine monophosphate-activated 1340 
protein kinase (AMPK) pathway. Acetic acid is a building block for the biosynthesis of acetyl-1341 
coenzyme A (acetyl-CoA). During acetyl-CoA biosynthesis, adenosine triphosphate (ATP) is 1342 
consumed and adenosine monophosphate (AMP) is produced, increasing the AMP/ATP ratio 1343 
and leading to activation of the AMPK pathway. This causes a reduction in blood glucose levels 1344 
and concomitant glycogen biosynthesis (Sakakibara, Yamauchi, Oshima, Tsukamoto, & 1345 
Kadowaki, 2006). Another mechanism by which vinegar may reduce the postprandial blood 1346 
glucose level is via effecting delayed gastric emptying. Hlebowicz et al. (2007) demonstrated 1347 
that consumption of 30 mL of apple vinegar decreased the postprandial gastric emptying rate 1348 
by 10% (Hlebowicz et al., 2007). The stabilisation of the postprandial blood glucose level 1349 
through the mechanism described above may also increase postprandial satiety, thus reducing 1350 
dietary intake and, as such, a further increase in blood glucose (Chen et al., 2016). 1351 
There is evidence that vinegar consumption can also affect lipid metabolism and, by 1352 
association, promote weight loss. Studies, in particular in animal models, have highlighted that 1353 
vinegar consumption can increase the concentration of high-density lipoprotein (HDL) 1354 
cholesterol while reducing triglycerides, total cholesterol, and low-density lipoprotein (LDL) 1355 
cholesterol (Fushimi et al., 2006). Similar effects on lipid levels were observed in human 1356 
subjects displaying hyperlipidaemia and in obese individuals following consumption of apple 1357 
cider vinegar (Beheshti et al., 2012; Kondo, Kishi, Fushimi, Ugajin, & Kaga, 2009a). Obese 1358 
individuals, following long term apple vinegar consumption, also displayed significantly 1359 
reduced body weight and body mass index (Kondo et al., 2009a). Regulation of lipid 1360 
metabolism by vinegar intake is understood to be due to acetic acid, and, in a similar 1361 
mechanism to glycaemic control, via activation of the AMPK pathway. Activation of this 1362 
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pathway decreases the biosynthesis of lipids, specifically through inhibition of genes related to 1363 
fatty acid biosynthesis, and also increases their breakdown and excretion. It is suggested that 1364 
lipid oxidation, due to acetic acid for example, stimulates expression of certain oxidase 1365 
enzymes, resulting in lipolysis (Samad, Azlan, & Ismail, 2016).  The effect of acetic acid on 1366 
postprandial satiety, as mentioned above, may also have a role in simply decreasing food, and 1367 
thus fat, intake (Chen et al., 2016). Acetic acid, and thus vinegar, may have a role in reducing 1368 
hypertension (blood pressure) through inhibiting angiotensin-converting enzyme (ACE) which 1369 
reduces plasma levels of the strong vasoconstrictive, angiotensin II (Samad et al., 2016). 1370 
Few studies on the anticancer properties of vinegar or acetic acid are available. The effect of 1371 
kurosu, a Japanese rice vinegar on the proliferation of a number of human cancer cell lines, 1372 
including colon adenocarcinoma, lung carcinoma, breast adenocarcinoma, bladder carcinoma, 1373 
and prostate carcinoma cells has been studied. It was reported to up-regulate the expression of 1374 
enzymes involved in DNA repair and cell apoptosis in cells, and to inhibit the growth of all 1375 
tested cell lines in a dose-dependent manner (Nanda et al., 2004). Kurosu was also shown by 1376 
Baba et al. (2013) to inhibit the proliferation of human squamous cell carcinoma cells via 1377 
programmed necrosis (Baba, Higashi, & Kanekura, 2013). The antioxidative nature of certain 1378 
types of vinegar is also postulated to have a role in anticancer activity. Kibizu, a Japanese 1379 
vinegar made from sugar cane, inhibited the growth of human leukaemia cells due to its high 1380 
radical-scavenging capacity (Mimura et al., 2004). 1381 
While there is significant evidence linking vinegar consumption to the modulation of blood 1382 
glucose levels, scientific studies linking vinegar intake to other health benefits such as control 1383 
of lipid levels and anticancer effects remain equivocal (Johnston & Gaas, 2006). As shown in 1384 
Table 7, the majority of studies have been performed in animal models; therefore, more human 1385 
studies, including large-scale and long-term clinical trials are required before any definitive 1386 
health claims can be made (Karabiyikli & Sengun, 2017). 1387 
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 1388 
Health benefits associated with kombucha 1389 
As reported by Dufresne and Farnworth (2000), a myriad of health benefits have been attributed 1390 
to the consumption of kombucha, from protecting against diabetes to counteracting ageing and 1391 
improving eyesight, mostly based on drinkers testimonials, and few of which have been 1392 
investigated scientifically (Dufresne & Farnworth, 2000). Those health benefits that have been 1393 
studied have primarily been performed in animal models, with very little data related to studies 1394 
on humans (Jayabalan et al., 2014). Many of the claimed beneficial effects of kombucha have 1395 
been correlated with its antioxidant activity. This has been mainly attributed to the tea substrate 1396 
and the presence of tea polyphenols, Vitamin C and D-saccharic acid-1,4-lactone (DSL). 1397 
Kombucha tea has a higher polyphenol content than un-fermented tea which is hypothesised to 1398 
be due to structural modification of tea polyphenols by enzymes produced during fermentation 1399 
by bacteria and yeast (Jayabalan et al., 2014). The polyphenol content of kombucha, and thus 1400 
its antioxidant capacity can be dependent on a number of factors, such as, the fermentation time 1401 
and conditions, variety of tea substrate, and the kombucha culture microbiota, which itself can 1402 
vary depending of the substrate and fermentation conditions, and which, in turn determines the 1403 
nature of the metabolites produced and present in the final beverage. In kombucha prepared 1404 
with different types of tea, reducing power, hydroxyl radical scavenging ability, and anti-lipid 1405 
peroxidation were decreased, while total phenolic compounds and scavenging activity against 1406 
DPPH and the superoxide radical increased with a prolonged fermentation time (Jayabalan, 1407 
Subathradevi, Marimuthu, Sathishkumar, & Swaminathan, 2008). Preparation of kombucha 1408 
with different starter cultures of mixed AAB and a single yeast species on green tea had lower 1409 
antioxidant capacity compared to a native (complex culture) kombucha (Malbaša, Lončar, 1410 
Vitas, & Čanadanović-Brunet, 2011). In a recent study, the polyphenol content of kombucha 1411 
was shown to be dependent on fermentation temperature, with a higher level at low (20oC) 1412 
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compared to high (30oC) temperatures. This was linked to the varying species dominance at 1413 
the different temperatures (De Filippis, Troise, Vitaglione, & Ercolini, 2018). 1414 
Investigations in cell lines animal models found that kombucha can protect against 1415 
hepatotoxicity caused by several toxicants such as paracetamol, carbon-tetrachloride, aflatoxin 1416 
B1 and acetaminophen (Jayabalan, Baskaran, Marimuthu, Swaminathan, & Yun, 2010; Pauline 1417 
et al., 2001; Wang et al., 2014). Bellassoued et al. (2015) demonstrated that the high 1418 
thiobarbituric acid reactive substances (TBARS) concentration was significantly reduced in the 1419 
liver and kidney of rats fed with cholesterol-rich diets after the treatment with fermented tea 1420 
(Bellassoued et al., 2015). The anti-toxigenic effect of kombucha has been attributed to its 1421 
antioxidant activity and the hepatoprotective effects against acetaminophen were primarily 1422 
attributed to the presence of DSL (Wang et al., 2014). Early investigations of the potential 1423 
health effects and detoxifying capacity of kombucha had primarily attributed the effects to its 1424 
acidic composition; in particular, the ability of glucuronic acid to bind toxic components 1425 
(glucuronidation) and to increase their excretion from the body was cited. However, the 1426 
possibility that what was actually being measured in those early studies as glucuronic acid was 1427 
in fact 2KGA, has been debated (Dufresne & Farnworth, 2000). Indeed, the concentration of 1428 
glucuronic acid in kombucha may be as much as ten thousand times lower than that of GA 1429 
(Lončar, Petrovič, Malbača, & Verac, 2000). 1430 
Given that acetic acid is a primary metabolite of the microbial consortia in kombucha, it could 1431 
be hypothesised that those health benefits attributed to the presence of acetic acid, as observed 1432 
in vinegar, may also contribute to the potential health effects of kombucha, notwithstanding 1433 
the difference in acetic acid concentration between both fermented products. Srihari et al. 1434 
(2013a) observed that the daily administration for 45 days, of a kombucha extract, reduced 1435 
glycated haemoglobin and increased the plasma insulin level, thus demonstrating an 1436 
antiglycaemic effect. However, the authors attributed the effect mainly to the polyphenolic 1437 
62 
 
component of kombucha and non-specifically to the presence of organic acids and B-complex 1438 
vitamins (Srihari, Karthikesan, Ashokkumar, & Satyanarayana, 2013a). 1439 
Kombucha has for many decades been claimed by drinkers to have anticancer effects, even in 1440 
a population study conducted in 1951 in Russia by the “Central Oncological Research Unit” 1441 
and the Russian Academy of Sciences in Moscow. The antiproliferative activity of kombucha 1442 
produced from black tea has been demonstrated against a number of cancer cell lines, such as 1443 
HeLa (cervix epithelial carcinoma) and HT-29 (colon adenocarcinoma) cells (Cetojevic-Simin, 1444 
Bogdanovic, Cvetkovic, & Velicanski, 2008). In addition, an ethyl acetate extract of black tea 1445 
kombucha caused cytotoxic effects on 786-O (human renal carcinoma) and U2OS (human 1446 
osteosarcoma) cells and significantly reduced cell invasion and motility of these cells in 1447 
addition to A549 (human lung carcinoma) cells (Jayabalan et al., 2011). Srihari et al. (2013b) 1448 
demonstrated that a lyophilized extract of kombucha significantly reduced the survival of 1449 
prostate cancer cells via down regulation of angiogenesis stimulators (Srihari, Arunkumar, 1450 
Arunakaran, & Satyanarayana, 2013b). Again, the presence of polyphenols and their phenolic 1451 
degradation products, as a consequence of fermentation, have been generally attributed as the 1452 
anticancer bioactive compounds in kombucha. 1453 
Similar to those studies on the health effects of vinegar, many of those investigating similar 1454 
benefits associated with the consumption of kombucha tea have relied on in vitro and animal 1455 
model investigations. Therefore, clinical trials and further in vivo evaluations are necessary in 1456 
order to confirm the claimed health benefits of kombucha tea. In particular, it is questionable, 1457 
and data is necessary to support such claims, as to whether the efficacious concentrations for 1458 
the positive effects observed through in-vitro studies would be achievable in-vivo in humans.  1459 
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Regulatory aspects on the use of AAB as food cultures 1460 
The application of microbial food cultures in the production of fermented foods, used in both 1461 
traditional backslopping practices and in recent decades as defined starter cultures, has an 1462 
important role in ensuring the quality and safety of these products, in addition to imparting 1463 
desirable flavour, aroma and textural properties (Bourdichon et al., 2012a). Today, with the 1464 
large and every expanding variety of fermented foods and beverages that exists, and the 1465 
possibility of applying new strains and species in foods, where they previously may not have 1466 
been used, ensuring consumer safety is of prime importance. Following a brief description of 1467 
the regulations pertinent to microbial food cultures in the European Union (EU) and the United 1468 
States of America (USA), aspects related to the application of AAB will be considered. 1469 
 1470 
Microbial Food Cultures and Regulation in the European Union 1471 
In the EU, the European Food Safety Authority (EFSA) operates the Qualified Presumption of 1472 
Safety (QPS) approach (European Food Safety Authority, 2007). Hereby, a taxonomic unit 1473 
(usually species) that is notified to the EFSA is pre-assessed for its safety based on aspects such 1474 
as the associated body of knowledge, a history of apparent safe use in food, scientific literature, 1475 
clinical aspects and industrial application. In this approach, familiarity is a critical aspect to 1476 
support evidence of a microbial presumption of safety (Russo, Spano, & Capozzi, 2017). 1477 
Familiarity, as a concept, is “taken to include practical experience of use of the organism(s) 1478 
including its history of use for particular purposes and any body of literature on the biology of 1479 
the taxonomic unit” (European Food Safety Authority, 2005), which could be translated to the 1480 
body of knowledge supporting evidence for the historical use or consumption of such 1481 
microorganisms in fermented foods, with no apparent adverse effects. For those 1482 
microorganisms which have not traditionally been significantly consumed within the EU (prior 1483 
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to May 1997), or, are not generally associated with foods, the concept of a “novel food” has 1484 
been devised and is regulated separately (European Commission, 2015). 1485 
If a species is deemed safe by the EFSA Panel on Biological Hazards it is placed on the QPS 1486 
list which is published by EFSA (Ricci et al., 2017a). However, individual strains must still 1487 
satisfy certain criteria, or qualifications, before being applied in food (and beverages) or feed. 1488 
As an example, a generic qualification for all bacterial taxonomic units on the QPS list is that 1489 
strains should not harbour any acquired antimicrobial resistance genes to clinically relevant 1490 
antimicrobials (Ricci et al., 2017a). In addition, as an alternative to exclusion from the list, 1491 
certain bacterial species may have specific qualifications placed on them, which give them QPS 1492 
status, but only when used for a defined application (Leuschner et al., 2010). Thus, for those 1493 
species that are on the QPS list, they may be permitted for use in food or feed once the strain(s) 1494 
being applied satisfy the attached qualifications. All microorganisms not on the QPS list remain 1495 
subject to a full safety assessment (European Food Safety Authority, 2007). However, it is not 1496 
entirely clear, at least from documents and literature from EFSA, what constitutes a full safety 1497 
assessment. To this end, Pariza et al. (2015) proposed a decision tree that could be used for the 1498 
safety evaluation of both non-QPS and QPS strains (Pariza, Gillies, Kraak-Ripple, Leyer, & 1499 
Smith, 2015) (Figure 8). This will be discussed further below with relevance to AAB. In 1500 
addition, microbial cultures assessed under the novel foods regulation (and not on the QPS list) 1501 
must undergo a full safety assessment (Laulund, Wind, Derkx, & Zuliani, 2017). 1502 
The absence of a species from the QPS list does not necessarily imply a risk associated with its 1503 
use. Individual strains may be safe, but the body of knowledge may not be sufficient to exclude 1504 
any potential risk. In addition, the EFSA may not have been requested to date to evaluate the 1505 
taxonomic unit in question (Bourdichon et al., 2012a). It is also possible that, for some 1506 
microorganisms on the QPS list, EFSA may have been requested to evaluate a taxonomic unit 1507 
for use in a defined application, and the scope of the evaluation may have been narrow, to 1508 
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exclude only the potential risks associated with the application for which the microorganism 1509 
was notified. Such microorganisms are included on the list, with a qualification of a specific 1510 
use (e.g. QPS applies only when used for vitamin production). 1511 
There remains some ambiguity and uncertainty around the QPS approach and regulation, as 1512 
outlined by Laulund et al. (2017) (Laulund et al., 2017). It appears that microbial food cultures 1513 
with a history of safe use in food are considered as traditional food ingredients and are legally 1514 
permitted for use in food in the EU without pre-market authorisation. On the other hand, those 1515 
with no history of use in foods would be considered as novel food, and require full safety 1516 
assessment, as mentioned above. This seems to suggest that it would be possible to place a 1517 
product on the market that uses microbial cultures that have not undergone any safety 1518 
assessment, if the manufacture considers that such cultures have a historical safe use in food. 1519 
It also raises two questions. Firstly, what exactly defines microbial food cultures? Given the 1520 
use of the wording “history of safe” and “traditional food ingredients”, does this suggest 1521 
complex, multi-strain cultures? What about single strain starter cultures? Secondly, how is a 1522 
history of safe use defined and how can it be proven? To address these questions and the gaps 1523 
in the regulation, the European Food and Feed Cultures Association (EFFCA) have proposed 1524 
a definition of food cultures, which outlines what constitutes a microbial food culture. Their 1525 
2015 definition defines microbial food cultures as “safe live bacteria, yeasts or moulds used in 1526 
food production, and they are in themselves a characteristic food ingredient. FC [food culture] 1527 
preparations are formulations, consisting of concentrates (>108 CFU per g or mL) of one or 1528 
more live and active microbial species and/or strains, including unavoidable media components 1529 
carried over from the fermentation and components, which are necessary for their survival, 1530 
storage and to facilitate their application in the food production process, and are in some cases 1531 
standardised to a low count with carriers” (European Food and Feed Cultures Association, 1532 
2018). In addition, to address the question of cultures with a history of safe use in food, EFFCA 1533 
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have, in association with the International Dairy Federation (IDF), compiled an “Inventory of 1534 
Microorganisms with a documented history of use in food”, the first inventory of FC with a 1535 
documented significant use in food production before 1997 (Laulund et al., 2017). The first 1536 
IDF/EFFCA Inventory, published in 2002, and primarily addressing cultures used in the dairy 1537 
fermentation industry, was updated in 2012 with an expanded scope to include microbial 1538 
cultures used in a wider range of food products (including meat, vegetable, cereals, beverages 1539 
and vinegar) (Bourdichon et al., 2012b). One of the main criteria for inclusion in the inventory 1540 
is a documented presence in fermented foods, and not just an incidental isolate (Bourdichon et 1541 
al., 2012c). 1542 
 Therefore, it appears that a food producer could conceivably place a product on the market 1543 
that uses a single microbial culture or a number of cultures, which have an associated history 1544 
of safe use in food, proven due to their inclusion in the IDF/EFFCA Inventory, and therefore 1545 
without the need for pre-authorisation or safety assessment of the employed strains. However, 1546 
it is likely that food producers would preferably opt to assess the safety of any strains employed 1547 
as much as possible, primarily to ensure the safety of consumers, but secondly, to minimise 1548 
liability, especially if the species is not on the QPS list. 1549 
 1550 
Microbial Food Cultures and Regulation in the United States of America 1551 
In the USA, the Food and Drug Administration (FDA) operates the Generally Recognised as 1552 
Safe (GRAS) system. This system is applied to a wide range of ingredients and is not specific 1553 
to microbial FCs in the way that the EU QPS system is. Substances (including microbial 1554 
cultures) added to food can be considered either as additives or GRAS substances. If they are 1555 
considered as additives, then a pre-market authorisation by the FDA is required. However, if 1556 
their use pre-dates 1958, or they have GRAS status, then no pre-market approval is required 1557 
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(Russo et al., 2017). Achieving GRAS status is, similar to the QPS system, built on evidence 1558 
of safety; in the case of GRAS, this must be guaranteed, with reasonable certainty, through 1559 
examination of the body of knowledge (typically scientific publications) and the assessment 1560 
and consensus of a panel of experts as to the safety of the substance or FC under its conditions 1561 
for use (Bourdichon et al., 2012a). In contrast to QPS, the GRAS designation encompasses the 1562 
substance / microbial culture and its specific application or usage (e.g. in a particular type of 1563 
product), rather than applying solely to the microorganism itself; thus, while for QPS the 1564 
evaluation is at the level of the taxonomic unit (species), and applies to that unit independent 1565 
of application, GRAS designation can be at the species or strain level because the specific 1566 
application (including formulation, dosages etc.) is considered (Ricci et al., 2017b). 1567 
From a legal standpoint, with a GRAS determination the onus and liability are placed on the 1568 
food company, as a GRAS designation is issued based on evidence evaluated by the food 1569 
manufacturer and the panel of experts engaged by that company. This is in contrast to the food 1570 
additive designation, where the onus is placed to a greater degree on the FDA, where a full 1571 
safety assessment by the authority is required. However, by law, neither a GRAS determination 1572 
nor the notification to the FDA of the new use of a microbial culture is mandatory for a food 1573 
company (Russo et al., 2017). Nevertheless, performance of a safety evaluation and the 1574 
attainment of GRAS status would serve to reduce the liability on the food manufacturer.  1575 
 1576 
Safety aspects of AAB, with emphasis on G. oxydans 1577 
Unlike LAB which are today primarily applied as single, defined starter cultures, the 1578 
application of AAB is still via undefined, mixed or complex cultures, where the mode of 1579 
transfer of the microorganisms to the next fermentation is through the traditional process of 1580 
“backslopping”. This is, for example, the case for both traditional and industrial methods of 1581 
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acetous vinegar fermentation. This has been described to be, firstly, due to the nutritionally 1582 
fastidious nature of AAB, which are difficult to preserve as a dried starter; and, secondly, 1583 
vinegar is generally viewed as an inexpensive commodity and its production has therefore not 1584 
warranted the development or use of expensive starter cultures (Solieri & Giudici, 2009). This 1585 
is also the case for other fermented foods in which AAB play a dominant role; thus, as their 1586 
use has been seen as traditional and viewed as safe through a long history of use, this group of 1587 
microorganisms have not been considered to a large extent with regard to the regulations 1588 
surrounding microbial FCs. However, with the increasing consumer interest in fermented food 1589 
products it is foreseeable that the industry will require the future development of defined AAB 1590 
starter cultures, which will necessitate the safety evaluation of such strains. 1591 
The only AAB (and one of only two Gram-negative bacteria) listed on the QPS list is 1592 
Gluconobacter oxydans (EFSA Panel on Biological Hazards, 2018). G. oxydans was assessed 1593 
by the EFSA Panel on Biological Hazards for the first time in 2013 and recommended for the 1594 
QPS list. The species was subject to a qualification, however; QPS only applies when the 1595 
species is used for vitamin production (EFSA Panel on Biological Hazards, 2013). It is not 1596 
stated in the Scientific Opinion exactly why the qualification was put in place; the panel noted 1597 
the general non-pathogenic nature of the genus and species to humans and animals (De Muynck 1598 
et al., 2007), and a review of over 5,000 references raised no human or animal safety concerns. 1599 
The possible pathogenic effect of [unidentified or unstated] Gluconobacter species was 1600 
mentioned by two studies, however, these cases involved individuals with compromised 1601 
immune systems (Alauzet et al., 2010; Bassetti et al., 2013). While the panel noted the reported 1602 
rare occurrence of infections, as well as colonization with AAB in patients with underlying 1603 
chronic diseases and/or indwelling devices, and the potential of some Gluconobacter species 1604 
(although not G. oxydans) to be opportunistic pathogens (Alauzet et al., 2010), no article 1605 
reported safety concerns related to consumption of foods and feed. The potential for 1606 
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monobactam antibiotic production by strains of G. oxydans, as reported in one study in 1982 1607 
was noted (Wells et al., 1982), with a decision to follow this aspect in future QPS reviews. 1608 
Nevertheless, the Panel placed G. oxydans on the QPS list with a qualification that it applies 1609 
only when the species is used for vitamin production. While it was not stated why the panel 1610 
placed this qualification on the taxonomic unit, it was noted that the qualification was “relevant 1611 
for the intended use for which the species was notified”. Whether the Panel placed this 1612 
qualification on the taxonomic unit because of unanswered questions around the safety of the 1613 
species, or, considered the safety of the species only in the context of the notified (narrow) 1614 
application is not known (EFSA Panel on Biological Hazards, 2013). In the intervening time 1615 
period to the present (August 2018), no new safety concerns were raised by EFSA and G. 1616 
oxydans has been maintained on the QPS list (EFSA Panel on Biological Hazards, 2018). In 1617 
the USA, to date, no products using Gluconobacter species have been submitted to the FDA 1618 
for GRAS designation (Food and Drug Administration, 2018). 1619 
The 2012 IDF/EFFCA Inventory lists 3 genera of AAB, encompassing 18 species. Species 1620 
from the genera Acetobacter, Gluconacetobacter (some of which would now be 1621 
Komagataeibacter) and Gluconobacter are included for their roles in vinegar, vegetable, coffee 1622 
and cocoa fermentations (Bourdichon et al., 2012b). Thus, the historic and safe use of these 1623 
species, with relative certainty, is unquestionable. With regard to any future safety assessment 1624 
of these species, the following paragraphs will outline some important considerations, using 1625 
the decision tree outlined in Figure 8 to guide the discussion, and with emphasis on G. oxydans.  1626 
Strain characterisation and genome sequencing: It is generally accepted today that bacterial 1627 
isolates are identifiable to species level using molecular approaches such as 16S rRNA gene 1628 
sequencing (Weisburg, Barns, Pelletier, & Lane, 1991). In addition, whole genome sequencing 1629 
of strains is now commonly performed and can prove indispensable for the safety assessment, 1630 
providing additional insights into the genetic basis of strain safety. Different bioinformatics 1631 
70 
 
tools and databases can be used to screen for the presence of virulence factors and for antibiotic 1632 
resistance genes e.g. microbial virulence factors can be screened for using the MvirDb database 1633 
(Zhou et al., 2006), while the Comprehensive Antibiotic Resistance Database (McArthur et al., 1634 
2013) and ResFinder (Zankari et al., 2012) can be used to search for antibiotic resistance 1635 
determinants (Laulund et al., 2017). Currently, in the National Center for Biotechnology 1636 
Information (NCBI) database there are approximately 170 sequenced genomes of AAB strains 1637 
of the genera Acetobacter, Gluconacetobacter, Gluconobacter and Komagataeibacter, with 14 1638 
G. oxydans genomes, 5 of which are complete (NCBI, 2018).  1639 
Screening for undesirable attributes and metabolites: With regard to the AAB strain producing 1640 
virulence factors or toxins, a whole genome sequence can be used to screen for genetic elements 1641 
encoding such traits, as described above. Besides those studies detailed in the 2013 QPS update, 1642 
which highlighted the rare occurrence of AAB as potential opportunistic pathogens, such cases 1643 
related to individuals with underlying chronic diseases and/or indwelling devices (EFSA Panel 1644 
on Biological Hazards, 2013). In the case of G. oxydans, no further studies in the intervening 1645 
time period raised any new concerns (EFSA Panel on Biological Hazards, 2018). In addition, 1646 
their long history of safe use and the presence of many AAB species on the 2012 IDF/EFFCA 1647 
Inventory is testament, within the limits of reasonable certainty, to their safety when consumed 1648 
by healthy individuals. Unlike the LAB, some species of which are biogenic amine producers, 1649 
AAB have not been found to produce these toxigenic compounds (Landete, Ferrer, & Pardo, 1650 
2007). However, in-vitro tests can be performed on strains to identify biogenic amine 1651 
producers; in addition, the genome sequence of strains can be screened for putative responsible 1652 
amino acid decarboxylase genes (or their homologues). The question of antibiotic resistance is 1653 
fundamental in assessing the safety of a strain. Chiefly, the strain must be free of functional 1654 
and transferable antibiotic resistance genes. Proven intrinsic (natural) resistance is generally 1655 
acceptable; the resistance determinant must not be transferable – this is to prevent the 1656 
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horizontal or lateral transfer of (acquired) resistance to antimicrobials of human and veterinary 1657 
importance from FC microorganisms to (potentially pathogenic) commensal microorganisms 1658 
in the gut (Pariza et al., 2015). Unlike LAB, for which guidelines and procedures have been 1659 
developed by the regulatory authorities to inform the testing and interpretation of antibiotic 1660 
susceptibilities of this microbial group (EFSA FEEDAP, 2012; International Organization for 1661 
Standardization, 2010), no such distinct guidelines are in place for AAB. In this case, it is 1662 
recommended that methods described by the Clinical and Laboratory Standard Institute be 1663 
used. Again, the genome sequence can also be useful to search for genes conferring antibiotic 1664 
resistance, with particular focus on genes associated with mobile genetic elements (plasmids, 1665 
conjugative transposons) that would be potentially transferrable (Laulund et al., 2017). In the 1666 
2013 QPS update when G. oxydans was admitted to the QPS list, the Panel reported that no 1667 
evidence of resistance to antibiotics was found in any of the papers screened. According to 1668 
only one publication, strains of some Gluconobacter species, although not G. oxydans, may be 1669 
multi-resistant to some antimicrobial agents. In addition, such strains were isolated from 1670 
hospitalised patients and the nature of the resistance (intrinsic or acquired) was not investigated 1671 
(Alauzet et al., 2010). When performing antibiotic susceptibility testing of strains, it is 1672 
important to differentiate between intrinsic and acquired antibiotic resistance and have 1673 
knowledge of the potential for intrinsic resistance in the strains being assessed; for example, 1674 
bacteria differ in their susceptibility to penicillin G; Gram-positive bacteria are generally 1675 
sensitive, while most Gram-negative bacteria are naturally resistant because this compound 1676 
cannot penetrate the outer cell membrane  (Madigan et al., 2015). Gram-negative bacteria are 1677 
also resistant to glycopeptide antibiotics (such as vancomycin) for the same reason. Although 1678 
arguable, for food products where the microbial culture has been killed or inactivated (through 1679 
an intense pasteurisation, for example), it appears, at least in the past, that the presence of 1680 
acquired microbial resistance was not considered to be an issue and was acceptable (Russo et 1681 
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al., 2017). However, if these dead cells are damaged or lysed in some way, either because of 1682 
food processing steps or passage through the gastrointestinal tract, it should be considered 1683 
whether mobile genetic elements carrying antibiotic resistance genes could still be released 1684 
into the gut environment and taken up, for example, via transformation by other 1685 
microorganisms present (European Food Safety Authority, 2008). 1686 
The ability of microbial food cultures to produce antimicrobial agents is also appreciable 1687 
because such agents could select for resistance in the host bacterial population (Bourdichon et 1688 
al., 2012a). As mentioned above, the potential for monobactam antibiotic production by strains 1689 
of G. oxydans was reported in a 1982 study (EFSA Panel on Biological Hazards, 2013; Wells 1690 
et al., 1982). The Panel stated the decision to follow this aspect in future QPS reviews; however, 1691 
up to and including the latest QPS update, no further information has emerged. 1692 
In general, there is only a very small body of knowledge and few studies related to such safety 1693 
aspects of AAB - antimicrobial susceptibility and potential pathogenicity. More research is 1694 
required, research which will also inform regulatory authorities and enable the development of 1695 
guidelines which should 1) guide academia and industry on the safety testing of AAB strains 1696 
and 2) allow streamlining of the pre-market approval process for the use of such strains as 1697 
starter cultures in both traditional and novel food products. 1698 
Genetic modification: If a strain has been isolated from a natural environment or system (e.g. 1699 
a fermented food product produced by traditional methods), it is unlikely to have been 1700 
genetically modified. If the strain has been genetically modified, regulatory approval and an 1701 
assessment of the safety of the expressed product is required in many countries (Pariza, 2007). 1702 
Strain origin: Consideration of the origin of the microbial FC focuses on its isolation from a 1703 
food with a demonstrated history of safe consumption and its significant role in the production 1704 
and characteristics of that food. As outlined in previous sections in this review, AAB, in 1705 
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particular members of the genera Acetobacter, Gluconobacter, Gluconacetobacter and 1706 
Komagataeibacter, are key members in fermented food products such as vinegar and 1707 
kombucha (Table 1), which are often sources for the isolation of new strains. Such fermented 1708 
foods have a long history of safe consumption, particularly in Eastern Europe, Russia and Asia. 1709 
Therefore, the long history of safe consumption of members of the AAB is self-evident. 1710 
Nonetheless, non-food products such as flowers can also be sources of new AAB strains; the 1711 
acceptability of the use of such strains, not strictly satisfying the guidelines of having been 1712 
isolated from food, could be an important topic for discussion.  1713 
The safety of a strain can only be assessed based on the existing body of scientific knowledge. 1714 
In addition, this knowledge should be assessed by an authoritative group and/or a group of 1715 
qualified scientific experts (Pariza et al., 2015). While G. oxydans is on the QPS list, with 1716 
qualifications, no other AAB has yet been placed on the list. However, as outlined above, 8 1717 
species, including G. oxydans, are included in the 2012 IDF/EFFCA Inventory (Bourdichon et 1718 
al., 2012b). Thus, the IDF/EFFCA Panel would be considered as an authoritative group of 1719 
scientific experts, and their inclusion of these AAB in the Inventory should be considered as 1720 
an affirmation, with reasonable certainty, of their safety. Nevertheless, such expert evaluations 1721 
should not be taken alone to constitute the absolute safety of a species and it is important to 1722 
consider, particularly when dealing with individual strains, the safety of a culture with respect 1723 
to the results of in-vitro tests and an analysis of the genome. In addition, it is noteworthy that 1724 
the term safe or safety, in this context, means that that there is a reasonable certainty in the 1725 
minds of competent scientists that a substance or microorganism is not harmful under the 1726 
intended conditions of use. However, as observed by Lauland et al. (2017), it is impossible in 1727 
the present state of scientific knowledge to establish with complete certainty the absolute 1728 
harmlessness of the use of any microorganism (Laulund et al., 2017). It is also important to 1729 
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consider recent scientific findings that may have emerged since the last peer review or scientific 1730 
evaluation, to ensure that the safety of a species is still valid. 1731 
Exposure levels: The level of exposure of consumers to any new microbial FC could be 1732 
dependent on a number of factors, such as the proposed applications of the strain, the number 1733 
of different food products in which the strain will be applied, the amount of the strain (inoculum 1734 
and final cell counts) within the product and the (post-fermentation) product processing 1735 
conditions. A key consideration is whether groups (e.g. age groups, groups with particular 1736 
medical conditions) which have not traditionally consumed or been exposed to the strain, will 1737 
be thus through its use as a starter culture or probiotic (Laulund et al., 2017). With respect to 1738 
AAB, the fact that certain populations may not have significantly consumed products produced 1739 
by this group of microorganisms (i.e. acetous fermented food and beverages) to a large extent 1740 
in the past should be considered e.g. Western European counties where kombucha has not 1741 
traditionally been consumed. Nevertheless, if the consumption of such products has been 1742 
considered, historically, to be safe in one population (e.g. in Asia), it is unlikely to be harmful 1743 
to another, albeit the gastrointestinal microbiota might be diet dependent.  1744 
Any processing performed on the final food or beverage product may also effect the level of 1745 
exposure to a microbial FC. For example, pasteurisation processes, depending on the conditions 1746 
chosen, may significantly reduce the number of viable cells remaining. In addition, there is the 1747 
option to completely inactivate the strain through an intense heat treatment. This may be 1748 
advisable if there is a contraindication to having live cells in the final product. An example of 1749 
this is the approval by EFSA in 2015 of the use of Bacteroides xylanisolvens DSM 23964 as a 1750 
novel food for use in fermented milk products, under the Novel Food Regulation No 258/97 1751 
(EFSA Panel on Dietetic Products, 2015; European Commission, 1997). The usage of the strain 1752 
was restricted to the fermentation of pasteurized milk products and only heat-treated (75oC for 1753 
1 hour) and therefore inactivated cells of B. xylanisolvens were allowed in the final product. At 1754 
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the same time, the EFSA Panel on Biological Hazards carried out a QPS assessment of the 1755 
species; however, while no safety concerns could be identified the panel found that the 1756 
published studies about B. xylanisolvens were too few and not sufficient to definitively exclude 1757 
safety issues. Therefore, the microorganism was not included on the QPS list. The fact that the 1758 
strain under investigation had no history of use in the food industry, and no strain in the genus 1759 
Bacteroides has a proven history of use in food production was also considered. In addition, a 1760 
gene encoding β-lactam antibiotic resistance was found in the genome. However, no mobile 1761 
genetic elements were found, and the Panel considered the transfer of genes therefore unlikely 1762 
due to this fact, in addition to the heat inactivation of the cells (Brodmann et al., 2017; EFSA 1763 
Panel on Biological Hazards, 2015). Even though B. xylanisolvens was not placed on the QPS 1764 
list, the positive outcome in terms of designation as novel food opens the possibility of using 1765 
other species or strains of bacteria as microbial FC, even if the body of knowledge is 1766 
insufficient and/or safety concerns cannot be fully excluded; however, with the qualification 1767 
that no viable cells remain in the product. This is noteworthy if the strain has been applied for 1768 
reasons beyond its fermentative capacity – for example, as viability is an essential condition 1769 
for probiotic activity, inactivated cells should not be promoted for their potentially probiotic 1770 
properties, and statements such as “contains live and active cultures” should not be made if the 1771 
microbial FC has been inactivated. Nevertheless, non-viable cells may still elicit immunogenic 1772 
effects and may have health benefits, hence, the term “paraprobiotic” has been coined to 1773 
describe such cultures (Taverniti & Guglielmetti, 2011). 1774 
As an aside, one commercial beverage product which is produced via a Gluconobacter oxydans 1775 
fermentation of malt-base (wort, or similar sugar source) is Bionade® [patent: DE4012000A1]. 1776 
Following the fermentation, the G. oxydans cells are stated to be removed via filtration 1777 
(www.bionade.de/en/production-process). 1778 
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In conclusion, in light of their long history of safe consumption, it appears unlikely that the 1779 
application of certain species of AAB (e.g. Acetobacter, Gluconobacter) would pose a safety 1780 
risk. However, in the interest of consumer safety it would be prudent that any strains of AAB, 1781 
applied as microbial FC in the future, would be thoroughly evaluated for their safety using a 1782 
QPS approach or following a decision tree similar to that shown in Figure 8. However, 1783 
relatively few studies have been conducted with regard to the safety of this microbial group, 1784 
which means that the body of scientific knowledge in the area is lacking, especially when 1785 
compared to the LAB (for example, prevalence and breadth of resistance to antimicrobials, 1786 
production of toxins etc.). In addition, distinct guidelines from the responsible regulatory 1787 
authorities (e.g. EFSA) are required, that deal with this important microbial group; however, it 1788 
is clear and understood that such guidelines can only be built on a pre-existing body of scientific 1789 
knowledge.  1790 
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Conclusion 1791 
AAB are most commonly known for their role in vinegar production, yet, this diverse group of 1792 
bacteria play an important part in the production of other fermented products such as kombucha 1793 
and water kefir. Their highly efficient oxidative metabolism is unique and can be harnessed for 1794 
the production of compounds that find application not only in the food and beverage area e.g. 1795 
GA, ascorbic acid, cellulose. The diversity of uses for this group of bacteria is particularly 1796 
highlighted by Gluconobacter oxydans. However, an understanding of their characteristics and 1797 
metabolism is critical to maximising the potential of these bacteria, especially with respect to 1798 
their strict oxidative requirements. Therefore, such an understanding of their metabolism can 1799 
be applied to enable process optimisations for decreased process times or increased product 1800 
yields, for example. In addition, further research may likely uncover other additional metabolic 1801 
transformations performed by these bacteria which may have as yet unknown important 1802 
applications.  1803 
With rising consumer interest in fermented foods and beverages, linked to purported health 1804 
benefits (both scientifically proven and anecdotal) and an increasing strive by consumers 1805 
towards a more health-conscious lifestyle, the AAB, like the LAB, are well poised for future 1806 
exploitation – both in the re-imagining of traditional foods or beverages, such as kombucha, 1807 
and in the development of new types of products. However, further and more extensive studies 1808 
and trials are needed with regard to the health benefits related to the consumption of AAB-1809 
fermented products. In addition, guidance needs to be put forward by the relevant regulatory 1810 
authorities, regarding the safety aspects of the application of this important group of 1811 
microorganisms. However, it is clear that more fundamental studies on the safety aspects of 1812 
this microbial group are required, upon which guidance from regulatory authorities can be 1813 
based.  1814 
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Table 1: Acetic acid bacteria commonly isolated from vinegar and fermented beverages 2794 
Food product AAB species found associated 
with the fermentation 
References 
Vinegar (Traditional 
Balsamic Vinegar) 
Acetobacter pasteurianus,  
A. aceti, Komagataeibacter xylinus, 
K. europaeus, K. hansenii 
(De Vero et al., 2006), 
(Gullo, Caggia, De Vero, & Giudici, 
2006), 
Kombucha K. xylinus, A. pasteurianus, K. 
hansenii, A. aceti, Ga. 
saccharivorans, other Acetobacter, 
Gluconobacter, and 
Gluconacetobacter spp. 
(Jayabalan et al., 2014), (Tan et al., 
2012), (Liu et al., 1996), (Wang et 
al., 2014), (Marsh et al., 2014) 
Water kefir A. lovaniensis, A. fabarum, A. 
cerevisiae, A. aceti, A. ghanensis, 
A. lovaniensis/fabarum, A. sicerae 
(Magalhaes et al., 2010), (Miguel, 
Cardoso, Magalhães, & Schwan, 
2011), (Gulitz et al., 2013) (Stadie, 
Gulitz, Ehrmann, & Vogel, 2013), 
(Laureys & De Vuyst, 2014) 
Lambic beer A. lambici, G. cerevisiae (De Roos & De Vuyst, 2018a, 
2018b; Spitaels et al., 2014b; 
Spitaels et al., 2014c) 
 2795 
 2796 
 2797 
 2798 
 2799 
 2800 
 2801 
 2802 
 2803 
 2804 
 2805 
 2806 
 2807 
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Table 2: Key characteristics of the four genera of AAB commonly associated with food 2808 
Characteristic Acetobacter Gluconobacter Gluconacetobacter Komagataeibacter 
Type strain A. aceti 
NBRC 
14818T 
G. oxydans 
NBRC 14819T 
Ga. liquefaciens 
NBRC 12388T 
K. xylinus JCM 
7644T 
Production of acetic acid 
from ethanol 
+ + + + 
Flagellation Per Pol Per N 
Oxidation of (to CO2 and 
H2O) 
    
Acetate + - + + 
Lactate + - + + 
Growth on     
30% glucose (w/v) - -b - nd 
1% glucose (w/v) + + + + 
Glutamate agar - - + + 
Mannitol agar vw + + + 
Raffinose - - - nd 
Utilisation of methanol - - - nd 
Growth in the presence 
of 
    
0.35% acetic acid (w/v) + + + + 
1% KNO3 (w/v) - - - nd 
Water soluble brown 
pigment production 
- -b + - 
Production of 
dihydroxyacetone from 
glycerol 
+ + + + 
Production of levan-like 
polysaccharide 
- -b - -b 
Assimilation of 
ammoniac nitrogen on 
    
Glucose - + + nd 
Mannitol - + + + 
Ethanol w - - nd 
Production of     
2-ketogluconate + + + + 
5-ketogluconate + + + + 
2,5-diketogluconate - -b + - 
Acid production from     
Mannitol - + - - 
Sorbitol - + - - 
Dulcitol - w - nd 
Glycerol - + - nd 
Raffinose - - - nd 
Ethanol + + + + 
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Per: peritrichous; Pol: polar; N: none; +, positive; -, negative; nd, not determined; b: some 2809 
strains in the genus are positive; w, weakly positive; vw, very weakly positive. Modified from 2810 
Yamada, 2016. 2811 
 2812 
 2813 
 2814 
 2815 
 2816 
 2817 
 2818 
 2819 
 2820 
 2821 
 2822 
 2823 
 2824 
 2825 
 2826 
 2827 
 2828 
 2829 
 2830 
 2831 
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Table 3: Media commonly used for the growth of AAB and their composition 2832 
Ingredient (%) GYC AE YPM MYA DMS mDMS 
Glucose 10 0.5 - - 0.1 0.1 
Yeast extract 1 0.3 0.5 0.5 0.3 0.3 
Peptone - 0.4 0.3 - 1.0 1.0 
Calcium carbonate 2 - - - -  
Ethanol - 3 - 6 - 0.5 
Glacial acetic acid - 3 - - - 0.3 
Lactic acid - - - - - 0.6 
Mannitol - - 2.5 - 0.1 0.1 
Sorbitol - - - - 0.1 0.1 
Malt extract - - - 1.5 - - 
Calcium lactate - - - - 1.5 - 
Potassium phosphate - - - - 0.1 0.1 
Sodium deoxycholate - - - - 0.01 0.01 
Magnesium sulfate - - - - 0.002 0.002 
Bromocresol - - - - 0.003 0.003 
Bacteriological agar 1.5 0.9 1.2 1.5 1.0 1.8 
GYC, glucose-yeast extract-calcium carbonate; AE, acetic acid-ethanol; YPM, yeast extract-peptone-mannitol; 2833 
MYA, malt extract-yeast extract-acetic acid; DMS, deoxycholate-mannitol-sorbitol; mDMS, modified 2834 
deoxycholate-mannitol-sorbitol. 2835 
 2836 
 2837 
 2838 
 2839 
 2840 
 2841 
 2842 
 2843 
 2844 
 2845 
 2846 
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 2847 
Table 4: Primary membrane-bound dehydrogenases of AAB performing oxidative 2848 
fermentations. 2849 
Enzyme Abbreviation Prosthetic 
group 
Substrate Product Importance References 
Alcohol 
dehydrogenase 
ADH PQQ Ethanol Acetaldehyde Vinegar 
production 
(Yakushi & 
Matsushita, 
2010) 
Aldehyde 
dehydrogenase 
ALDH MCD Acetaldehyde Acetic acid Vinegar 
production 
(Thurner et 
al., 1997) 
Glucose 
dehydrogenase 
GDH PQQ D-glucose δ-glucono-lactone Gluconate and 
keto-gluconate(s) 
production 
(Ameyama, 
Shinagawa, 
Matsushita, 
& Adachi, 
1981b) 
Gluconate 
dehydrogenase 
GADH FAD D-gluconate 2-keto-D-
gluconate 
Gluconate and 
keto-gluconate(s) 
production 
(Shinagawa, 
Matsushita, 
Adachi, & 
Ameyama, 
1984) 
2-keto-D-
gluconate 
dehydrogenase 
GADH FAD 2-Keto-D-
gluconate 
2,5-diketo-D-
gluconate 
Gluconate and 
keto-gluconate(s) 
production 
(Toyama et 
al., 2007) 
Glycerol 
dehydrogenase 
GLDH PQQ (Polyols) (ketones) Polyol oxidation (Matsushita 
et al., 2003) 
   D-gluconate 5-keto-D-
gluconate 
  
   Glycerol Dihydroxyacetone   
   D-mannitol D-fructose   
   D-sorbitol L-sorbose   
   D-arabitol D-xylulose   
   Ribitol L-ribulose   
   Meso-
erythritol 
Erythrulose   
Sorbitol 
dehydrogenase 
SLDH FAD D-sorbitol L-sorbose Vitamin C 
production 
(Shinagawa, 
Matsushita, 
Adachi, & 
Ameyama, 
1982) 
L-sorbose 
dehydrogenase 
SDH FAD L-sorbose L-sorbosone Potential Vitamin 
C production 
(Sugisawa, 
Hoshino, 
Nomura, & 
Fujiwara, 
1991) 
L-sorbosone 
dehydrogenase* 
SNDHai PQQ L-sorbosone L-ascorbic acid Potential Vitamin 
C production 
(Berry et al., 
2003; 
Pappenberger 
& Hohmann, 
2014) 
Fructose 
dehydrogenase 
FDH FAD D-fructose 5-keto-D-fructose Potential low-
calorie sweetener 
(Ameyama, 
Shinagawa, 
Matsushita, 
& Adachi, 
1981a) 
Quinate 
dehydrogenase 
QDH PQQ Quinate 3-dehydroquinate Precursor for 
protocatechuic 
acid production 
(Vangnai et 
al., 2004) 
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(antioxidant and 
anti-
inflammatory 
compound) 
Myo-Inositol 
dehydrogenase 
IDH PQQ Myo-inositol 2-keto-myo-
inositol 
No clear 
industrial 
importance 
(Hoelscher, 
Weinert-
Sepalage, & 
Goerisch, 
2007) 
Glycerol 
dehydrogenase 
GLDH PQQ (N-
hydroxyethyl)- 
1-amino-1-
deoxy-d-
sorbitol  
(N-hydroxyethyl)-
6-amino-6- 
deoxy-l-sorbose 
Production of the 
antidiabetic 
drugs, 1-
deoxynojirimycin 
and miglitol   
(Schedel, 
2000) 
*Note: Another enzyme of the same name, SNDH-FAD, is located in the cytoplasm and 2850 
converts L-sorbosone to 2-keto-L-gulonic acid. 2851 
 2852 
 2853 
 2854 
 2855 
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Table 5. Definition of vinegar around the world. 2856 
 2857 
Regulation Definition Reference 
Malaysian Food Act 1983 
and Food Regulation 1985, 
 
Liquid product prepared from the alcoholic fermentation and subsequent acetous fermentation of any 
suitable food. The final product shall not contain less than 4 percent weight per volume (w/v) of acetic 
acid and shall not contain any mineral acid. The vinegar may also contain permitted preservatives, 
caramel as a colouring substance and spices as permitted flavouring substances  
 
(Malaysian Food 
Regulations, 1985) 
Codex Alimentarius 
Commission 
Liquid suitable for human consumption and produced exclusively from appropriate products containing 
starch or sugars or starch and sugars by double fermentation processes, alcoholic and acetous. Vinegar 
shall not contain more than 0.5% alcohol, and stabiliser is not permitted for use in fermented vinegars 
according to European law. The vinegar itself shall not contain less than 50 g per litre (w/v) of acetic 
acid 
 
(Codex Alimentarius 
Commission, 1987) 
U.S. Food and Drug 
Administration (FDA) 
There are no standards of identity for vinegar established under the Federal Food, Drug and Cosmetic 
Act. Nevertheless, the FDA considers that an acceptable guideline for vinegars that they must contain 
in excess of 4 g of acetic acid per 100 mL. Vinegar is made by the alcoholic and subsequent acetous 
fermentation of fruit juice 
 
(United States of 
America Food and 
Drug Administration, 
1977) 
Commission Regulation 
(EU) 2016/263 
1) Liquid produced by double fermentation, i.e., alcoholic and acetic from agricultural origin such as 
fruit, cereal, grains, wine, cider or malt. Plants or part of plants, including fruit, spices, salt or 
sugar may be added for flavouring. 
2) Diluted acetic acid (diluted with water to 4-30 % by volume). 
 
(European 
Commission, 2016) 
Food Standards Australia 
New Zealand 2.10.1 
Sour liquid prepared by the acetous fermentation with or without alcoholic fermentation of any suitable 
foodstuff and includes blends and mixtures of vinegar. This vinegar must contain not less than 40 g/kg 
of acetic acid. 
 
(Food Standards 
Australia New Zealand 
Act, 1991) 
Food Safety and Standards 
Authority of India 
Products obtained by the alcoholic and acetic acid fermentation of any suitable medium such as fruit, 
malt, or molasses, with or without the addition of caramel and spices. They shall not be fortified with 
acetic acid. The acidity, calculated as the acetic acid content, shall not be less than 3.75% (m/v), the 
total solids (m/v) shall not less than 1.5%, and the total ash content shall not be less than 0.18% 
 
(Food Safety and 
Standards Authority of 
India, 2012) 
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 2858 
 2859 
 2860 
 2861 
 2862 
 2863 
 2864 
 2865 
 2866 
The Ministry of Food and 
Drug Safety  -  Korea 
(MFDS) 
1) Brewed vinegar that is produced by fermenting grains, fruits or alcoholic drinks or by mixing and 
ripening them with a grain-saccharified solution or fruit juice  
2) Synthetic vinegar that is manufactured by diluting glacial acetic acid or acetic acid with drinking 
water.  
The total acid content is quantified as the acetic acid content, which is in the range of 4.0 to 29.0% 
(w/v), and tar colour should not be detected 
 
(Ministry of Food and 
Drugs Safety, 2014) 
Chinese National Standard 
code of condiments (2004) 
Edible vinegar. No.14834, 
N5239 
Products obtained  from both fermentation or artificial process (acetic acid blended with other 
ingredients, such as flavours) 
(Chinese National 
Standard, 2004) 
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Table 6. Overview of vinegars from around the world: raw materials, intermediate product, vinegar name and geographical distribution. 2867 
Category Raw material Edible part Intermediate Main carbon sources Vinegar name Geographical distributiond 
Vegetablea 
 
 
 
 
 
 
 
Bamboo sap 
Palm sap 
Tea and Sugar 
Onion 
Tomato 
Sugarcane 
 
 
Bamboo sap 
Sap (xylem fluid) 
 
Bulbs 
 
Stalks 
 
Fermented bamboo sap 
Palm wine (toddy, tari, tuack, tuba) 
Kombucha 
Onion alcohol 
- 
Fermented sugar cane juice 
Basi 
 
Sucrose 
Sucrose 
Sucrose 
Fructose, glucose, sucrose 
 
Sucrose 
 
 
Bamboo vinegarb 
Palm vinegar, toddy vinegar 
Kombucha vinegar 
Onion vinegar 
Tomato vinegar 
Cane vinegar 
Sukang iloko 
Kibizu 
Japan, Korea 
Southeast Asia, Africa 
Russia, Asia (China, Japan, Indonesia) 
East and Southeast Asia 
Japan, East Asia 
France, USA 
Philippines 
Japan 
Grains Malt 
Rice 
 
Barley 
Millet 
Wheat 
Sorghum 
Seeds (caryopsis) 
Seeds (caryopsis) 
 
Seeds (caryopsis) 
Seeds  
Seeds (caryopsis) 
Seeds (caryopsis 
Beer 
Koji/moromi 
 
Beer 
Koji/moromi 
Koji/moromi 
Koji/moromi 
Maltose 
Starch 
 
Starch 
Starch 
Starch 
Starch 
Malt vinegar 
Komesu, kurosu (Japanese) 
Heicu (Chinese) 
Vinegar 
Black vinegar 
Black vinegar 
Black vinegar 
Northern Europa, USA 
East and Southeast Asia 
 
Germany, Austria, Netherlands 
China, East Asia  
China, East Asia 
China, East Asia 
Fruit Apple 
Grape 
 
 
 
Coconut 
Date 
Mango 
Red date 
Raspberry 
Black currant 
Blackberry 
Mulberry 
Plum 
Cranberry 
Kaki 
Fruit (pome) 
Fruits (berry) 
 
 
 
Coconut water 
Fruits (drupe) 
Fruits 
Fruits (drupe) 
Fruits (berry) 
Fruits (berry) 
Fruits (berry) 
Fruits (berry) 
Fruits (drupe) 
Fruits (drupe) 
Fruit (pome) 
 
Cider 
Raisin 
Red or white wine 
Sherry wine 
Cooked must 
Fermented coconut water 
Fermented date juice 
Fermented mango juice 
Fermented jujube juice 
Fermented raspberry juice 
Fermented black currant juice  
Fermented blackberry juice 
Fermented mulberry juice 
Umeboshic fermented plum juice 
Fermented cranberry juice 
Fermented persimmon juice 
 
Fructose, glucose, sucrose 
Fructose, glucose 
 
 
 
Glucose, fructose 
Sucrose 
 
Sucrose 
Fructose, glucose 
Fructose, glucose 
Fructose, glucose 
Fructose, glucose 
Sucrose, fructose, glucose 
Fructose, glucose 
Fructose, glucose, sucrose 
 
Cider vinegar 
Raisin (grape) vinegar 
Wine vinegar 
Sherry (jerez) vinegar 
Balsamic vinegar 
Coconut water vinegar 
Date vinegar 
Mango vinegar 
Jujibe vinegar 
Raspberry vinegar 
Blackcurrant vinegar 
Blackberry vinegar 
Mulberry vinegar 
Ume-su 
Cranberry vinegar 
Persimmon vinegar 
Kakisu 
USA, Canada 
Turkey and Middle East 
Widespread 
Spain 
Italy 
Philippines, Sri Lanka 
Middle East 
East and Southeast Asia 
China 
East and Southeast Asia 
East and Southeast Asia 
East and Southeast Asia 
East and Southeast Asia 
Japan 
East and Southeast Asia 
South Korea 
Japan 
Animal Whey 
Honey 
Whey 
Honey 
Fermented whey 
Diluted honey win, tej 
Lactose 
Fructose, glucose 
Whey vinegar 
Honey vinegar 
Europe 
Europe, America, Africa 
aVegetable is not a botanical term and is used to refer to an edible plant part; some botanical fruits, such as tomatoes, are also generally considered to be vegetables.  b Obtained by bamboo sap fermentation (González 2868 
& De Vuyst, 2009).  2869 
c Umeboshi are pickled ume fruits. Ume is a species of fruit-bearing tree of the genus Prunus, which is often called a plum but is actually more closely related to the apricot. d Listed in order, from the largest to the 2870 
smallest amount. 2871 
Reprinted with permission from (Solieri & Giudici, 2009). 2872 
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Table 7. Studies examining the potential health benefits associated with vinegar consumption. 2873 
Vinegar type Function Country Subject(s) Results Reference 
Spirit vinegar Antibacterial Japan 
Food-borne pathogenic 
bacteria 
The growth of all strains evaluated was inhibited with a 
0.1% concentration of acetic acid in the vinegar. (Entani et al., 1998) 
Rice vinegar Antibacterial China E. coli O157:H7 
Treatment of inoculated lettuce (107 CFU/g bacteria) with 
vinegar (5% acetic acid) for 5 min would reduce 3 logs 
population at 25 °C. 
(Chang & Fang, 2007) 
Grape vinegar Antibacterial Turkey 
Salmonella 
typhimurium 
Treatment of carrot samples with vinegar (4.03% acetic 
acid) for different exposure times (0, 15, 30 and 60 min) 
caused significant reductions ranging between 1.57 and 
3.58 log CFU/g. 
(Sengun & Karapinar, 2004) 
Acetic acid 
solution 
Anti-infection Kuwait 
96 patients with 
chronic suppurative 
otitis media 
The patients received ear irrigation with 2% acetic acid 
solution three times per week (3 weeks, followed for up to 
3 years). 55 patients had resolution of their original 
otorrhen, whereas 19 patients developed healed ear drum 
perforation. 14 patients (15%) showed recurrence and 8 of 
them had no response to the treatment. 
(Aminifarshidmehr, 1996) 
Fermented 
vinegar 
Anti-infection Korea 
15 patients with 
chronic granular 
myringitis 
The patients were treated with irrigation of the external 
canal with dilute vinegar solution (pH = 2.43) twice to 
four times per day. All patients had resolution of their 
original otorrhoea within three weeks. 
(Jung, Cho, Yoo, Lim, & Chae, 
2002) 
Shanxi aged 
vinegar 
Antioxidative China Hyperlipidemic mouse 
Fed with a diet with 1% freeze-dried powder of Shanxi 
aged vinegar for 35 d resulted in a significant increase in 
antioxidant activity in mice. 
(Liu & Yang, 2015) 
Zhenjiang 
aromatic vinegar 
Antioxidative China 
Ageing accelerating 
mice 
Instilled with 1.2 g/kg/d vinegar for 35 d resulted in a 
significant increase in antioxidant activity in mice. (Xu, Tao, & Ao, 2005) 
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Kurosu Antioxidative Japan Mice 
The ethyl acetate extract of Kurosu significantly 
suppressed the 12-O- tetradecanoylphorbol-13-acetate 
induced myeloperoxidase activity and H2O2 generation in 
mouse. 
(Nishidai et al., 2000) 
Traditional 
balsamic vinegar 
Antioxidative Italy In vitro 
Reducing capacity: 218.85 ± 6.86 mg Vc/100 mL 
Antiradical activity: 298.10 ± 6.25 mg Vc/100 mL (Tagliazucchi et al., 2008) 
Traditional 
balsamic vinegar 
Antioxidative Italy In vitro 
Reducing capacity: 27.12 ± 11.1 μM Tes/mL Antiradical 
activity: 33.52 ± 19.3 μM Tes/mL (Bertelli et al., 2015) 
Traditional 
balsamic vinegar 
Antioxidative Italy Simulated gastric 
The vinegar melanoidins (4.5 mg/mL) significantly 
inhibited the lipid peroxidation during simulated gastric 
digestion of meat. 
(Verzelloni et al., 2010) 
Balsamic vinegar Antioxidative Japan Macrophage:THP-1 
Balsamic vinegar (0.01%) significantly inhibited the low 
density lipoprotein (LDL) oxidation and lipid 
accumulation in macrophages 
(Iizuka et al., 2010) 
Red wine vinegar Antioxidative Italy In vitro 
Reducing capacity: 48.18 ± 2.00 mg Vc/100 mL 
Antiradical activity: 85.40 ± 1.73 mg Vc/100 mL (Verzelloni et al., 2007) 
White vinegar 
Blood glucose 
control 
Sweden 12 healthy volunteers 
Supplementation of a meal with vinegar (18 g) reduced 
postprandial responses of blood glucose and insulin and 
increased the subjective rating of satiety. 
(E. Östman, Granfeldt, 
Persson, & Björck, 2005) 
Bitter buckwheat 
vinegar 
Blood glucose 
control 
China Diabetic rats 
Oral intake of vinegar (2 mL/kg/d) for 4 weeks reduced 
about 17% blood glucose in rats. (Ma, Xia, & Jia, 2010) 
Rice vinegar 
Blood glucose 
control 
China Diabetic rats 
Oral intake of vinegar (2 mL/kg/d) for 30 d improved 
fasting hyperglycemia and body weight loss through 
attenuating insulin deficiency, pancreatic beta-cell deficit, 
and hepatic glycogen depletion in rats. 
(Gu et al., 2012) 
Apple vinegar 
Blood glucose 
control 
America 
11 patients with type 2 
diabetes 
Vinegar ingestion (30 mL) at bedtime moderates waking 
glucose concentrations in adults with well-controlled type 
2 diabetes mellitus. 
(White & Johnston, 2007) 
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Apple vinegar 
Blood glucose 
control 
America 
27 patients with type 2 
diabetes 
Oral intake of vinegar (1.4g/d) for 12 weeks significantly 
reduced haemoglobin A1c values in individuals with type 
2 diabetes mellitus. 
(Johnston et al., 2009) 
Apple vinegar 
Blood glucose 
control 
America 8 healthy volunteers 
Supplementation of a meal with vinegar (10 g) reduced 
about 23% postprandial responses of blood glucose. (Johnston et al., 2010) 
Apple vinegar 
Blood glucose 
control 
Japan 
7 patients with 
polycystic ovary 
syndrome 
Oral intake of vinegar (15 g/d) for 90 - 110 d improved 
insulin sensitivity in individuals with polycystic ovary 
syndrome. 
(Wu et al., 2013) 
Vinegar 
Blood glucose 
control 
Greece 
10 patients with type 1 
diabetes 
Supplementation of a meal with vinegar (30 mL) reduced 
about 20% postprandial responses of blood glucose. 
(Mitrou et al., 2010) 
Acetic acid 
solution 
Regulation of 
lipid metabolism  
Japan 
Human umbilical vein 
endothelial cell 
Vinegar intake enhances flow-mediated vasodilatation via 
upregulation of endothelial nitric oxide synthase activity. 
(Sakakibara et al., 2010) 
Shanxi aged 
vinegar 
Regulation of 
lipid metabolism 
China Hyperlipidemic mice 
Fed with a diet with 1% freeze-dried powder of vinegar 
for 35 d resulted in a significant reduction of triglyceride, 
total cholesterol and LDL in mouse. 
(Liu & Yang, 2015) 
Sorghum vinegar 
Regulation of 
lipid metabolism 
China Rats 
Fed with a diet with extract of vinegar (100 mg/kg) 
protected the rats against thrombotic death induced by 
collagen and epinephrine. 
(Fan et al., 2009) 
Grape vinegar 
Regulation of 
lipid metabolism 
Iran 
Rabbits with high 
cholesterol diet 
Oral intake of 10 mL vinegar significantly reduced LDL-
cholesterol, oxidized-LDL malondialdehyde and total 
cholesterol in rabbits after 3 hours. 
(Setorki, Asgary, Eidi, & 
Khazaei, 2010) 
Grape vinegar 
Regulation of 
lipid metabolism 
Egypt Diabetic rats 
Fed with a diet with 15% vinegar for 6 weeks 
significantly reduced LDL-cholesterol and total 
cholesterol in rats. 
(Soltan & Shehata, 2012) 
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Apple vinegar 
Regulation of 
lipid metabolism 
Iran 
19 patients with 
hyperlipidemia 
Oral intake of vinegar (30 mL/d, twice) for 8 weeks 
significantly reduced triglyceride, total cholesterol and 
LDL in individuals with hyperlipidemia. 
(Beheshti et al., 2012) 
Persimmon 
vinegar 
Regulation of 
lipid metabolism 
Korea 
Mouse with high lipid 
diet 
Oral intake of vinegar (2 mL/kg/d) for 16 weeks 
significantly reduced triglyceride and total cholesterol in 
mouse. 
(Moon & Cha, 2008) 
Acetic acid 
solution 
Weight loss Japan Obese mice 
Fed with 0.3 or 1.5% acetic acid solution for 6 weeks 
significantly inhibited the accumulation of body fat and 
hepatic lipids without changing food consumption or 
skeletal muscle weight. 
(Kondo, Kishi, Fushimi, & 
Kaga, 2009b) 
Corn vinegar Weight loss China Obese mice 
Oral intake of vinegar (0.3 mL/d) for 30 d significantly 
reduced body weight, fat coefficient, triglyceride and total 
cholesterol in mouse. 
(Li et al., 2009) 
Purple sweet 
potato vinegar 
Weight loss China Obese mice 
Oral intake of vinegar (10 mL/ kg/d) for 30 d significantly 
reduced body weight, fat coefficient, LDL, triglyceride 
and total cholesterol in mouse. 
(Liu et al., 2015) 
Apple vinegar Weight loss Japan 150 obese Japanese 
Oral intake of vinegar (15 mL/d) for 12 weeks 
significantly reduced body weight, body fat mass and 
serum triglyceride levels in subjects. 
(Kondo et al., 2009a) 
Apple vinegar Weight loss Mexico 
Rats with high-caloric 
diets 
Oral intake of vinegar (0.8 mL/ kg/d) for 4 weeks 
significantly reduced body weight, fat coefficient, LDL, 
triglyceride and total cholesterol in rats. 
(De Dios Lozano, Juárez-
Flores, Pinos-Rodríguez, 
Aguirre-Rivera, & Álvarez-
Fuentes, 2012) 
Mulberry vinegar Weight loss China Obese mice 
Oral intake of vinegar (0.1 mL/d) for 30 d significantly 
reduced body weight, fat coefficient, triglyceride and total 
cholesterol in mouse. 
(Wei et al., 2005) 
Hawthorn 
Vinegar 
Weight loss Turkey 
37 Obese patients with 
cardiovascular disease 
Oral intake of vinegar (40 mL/d) for 4 weeks significantly 
reduced body weight, body fat mass and serum 
triglyceride levels in subjects. 
(Kadas, Akdemir Evrendilek, 
& Heper, 2014) 
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Shanxi aged 
vinegar 
Anti-carcinogenic China 
Cancer cells (A549, 
Hep-G2, MDA-MDB-
231, HeLa) 
Ethyl acetate extract of vinegar (0.01%) significantly 
inhibited the proliferation of cancer cells in vitro. 
(Chen & Gullo, 2015) 
Kurosu Anti-carcinogenic Japan Rats with colon cancer 
Fed with water containing 0.05% ethyl acetate extract of 
Kurosu for 35 weeks significantly inhibited 
azoxymethane-induced colon carcinogenesis in rats. 
(Shimoji et al., 2004) 
Kurosu Anti-carcinogenic Japan 
Cancer cell (Caco-2, 
A549, MCF-7, 5637, 
LNCaP) 
Ethyl acetate extract of vinegar (0.025%) significantly 
inhibited the proliferation of cancer cells in vitro. 
(Nanda et al., 2004) 
Black soybeans 
vinegar 
Anti-carcinogenic Japan Leukaemia U937 cells 
Ethyl acetate extract of vinegar (10 mg/mL) significantly 
inhibited the proliferation of cancer cells in vitro. 
(Inagaki et al., 2007) 
Post-distillation 
slurry vinegar 
Anti-carcinogenic Japan 
Mice with Sarcoma 
180 and Colon 38 
tumour cells 
Fed with a diet with 0.5% vinegar for 72 d significantly 
decreased the sizes of tumours and prolonged life spans of 
mouse. 
(Seki, Morimura, Shigematsu, 
Maeda, & Kida, 2004) 
Sugarcane 
vinegar 
Anti-carcinogenic Japan 
Leukaemia cells: HL-
60, THP-1, Molt-4, U-
937, K-562 
Fraction eluted by 40% methanol from vinegar 
significantly inhibited the proliferation of leukaemia 
cells in vitro. 
(Mimura et al., 2004) 
Zhenjiang 
Aromatic 
Vinegar 
Anti-fatigue China Mouse 
Fed with a diet with vinegar (300 mg/kg/d) for 28 d 
significantly improved anti-fatigue abilities of mouse. (Lu & Zhou, 2002) 
Mulberry vinegar Anti-fatigue China Mouse 
Fed with a diet with vinegar (0.2 mL/d) for 20 d 
significantly improved anti-fatigue abilities of mouse. (Zhang, Li, & Du, 2007) 
Grain vinegar 
Prevention of  
osteoporosis 
Japan Ovariectomized rats 
Fed with a diet with 0.4% vinegar for 32 d significantly 
increased intestinal absorption of calcium in rats. (Kishi et al., 1999) 
Reproduced from Chen et al., 2016 with permission, and with slight modification2874 
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 2877 
Figure 1. Respiratory and oxidative fermentation chains and associated dehydrogenases in Acetic acid bacteria. 2878 
 2879 
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 2880 
 2881 
Figure 2. Strategies of acetic acid resistance employed by Acetic acid bacteria. a) adaption of and protection of intracellular proteins to and 2882 
against acid stress, b) metabolism (overoxidation) of intracellular acetic acid, c) efflux of acetic acid from the cell and d) prevention of acetic 2883 
acid from entering the cell.2884 
116 
 
 2885 
 2886 
 2887 
Figure 3. The process of wine vinegar-making from grape juice. 2888 
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 2904 
Figure 4. Schematic representation of vinegar production in submerged system. aAt concentrations 2905 
specified by legislation; b  Blending with high acidity vinegar, to block undesired alcoholic fermentation; 2906 
c nutrients containing carbon and nitrogen sources, vitamins and minerals are supplemented especially 2907 
to produce high acidity vinegar (>12% of acetic acid) from alcoholic stocks containing no carbon 2908 
sources except for ethanol. Reprinted with permission from Gullo et al., 2014. 2909 
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 2917 
Figure 5. Kombucha cellulose pellicle (SCOBY). 2918 
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 2928 
119 
 
 2929 
Figure 6. Different non-dairy products from sugary kefir fermentation. Reprinted with permission from 2930 
Fiorda et al., 2017. 2931 
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 2932 
Figure 7. Processes used in, or having the potential for, Vitamin C production. (a) The Reichstein Process, microbial production of L-sorbose from 2933 
D-sorbitol; (b) The Two-Step Fermentation Process, microbial production of 2-KLGA from L-sorbose via a 2-step fermentation; (c) Microbial 2934 
production of 2-KLGA by G. oxydans; (d) direct microbial production of Vitamin C by G. oxydans; (e) microbial production of 2-KLGA via the 2935 
2,5-diKGA pathway.  C: chemical reaction, M: microbial bioconversion.2936 
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 2937 
 2938 
 2939 
Figure 8. Decision tree for the safety assessment of microbial strains to be used in food 2940 
applications. Reprinted from Laulund et al., 2017. 2941 
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